{"_terms.yaml":{"id":"_terms","28s_16s_ribosomal_rna_ratio":{"description":"The 28S/18S ribosomal RNA band ratio used to assess the quality of total RNA.\n","termDef":{"term":"28s/18s Ribosomal RNA Ratio","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"a260_a280_ratio":{"description":"Numeric value that represents the sample ratio of nucleic acid absorbance at 260 nm and 280 nm, used to determine a measure of DNA purity.\n","termDef":{"term":"Nucleic Acid Absorbance at 260 And Absorbance at 280 DNA Purity Ratio Value","source":"caDSR","cde_id":5432595,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432595&version=1.0"}},"adapter_name":{"description":"Name of the sequencing adapter.\n"},"adapter_sequence":{"description":"Base sequence of the sequencing adapter.\n"},"age_at_diagnosis":{"description":"Age at the time of diagnosis expressed in number of days since birth. If the age at diagnosis is greater than 32872 days (89 years), then see 'age_at_diagnosis_gt89'.\n","termDef":{"term":"Patient Diagnosis Age Day Value","source":"caDSR","cde_id":3225640,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3225640&version=2.0"}},"age_at_diagnosis_gt89":{"description":"Indicate if the age at the time of diagnosis expressed in number of days since birth is greater than 32872 days (89 years).\n","termDef":{"term":"Patient Diagnosis Age Day Value","source":"caDSR","cde_id":3225640,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3225640&version=2.0"}},"ajcc_clinical_m":{"description":"Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.\n","termDef":{"term":"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","source":"caDSR","cde_id":3440331,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3440331&version=1.0"}},"ajcc_clinical_n":{"description":"Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.\n","termDef":{"term":"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","source":"caDSR","cde_id":3440330,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3440330&version=1.0"}},"ajcc_clinical_stage":{"description":"Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.\n","termDef":{"term":"Neoplasm American Joint Committee on Cancer Clinical Group Stage","source":"caDSR","cde_id":3440332,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3440332&version=1.0"}},"ajcc_clinical_t":{"description":"Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.\n","termDef":{"term":"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","source":"caDSR","cde_id":3440328,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3440328&version=1.0"}},"ajcc_pathologic_m":{"description":"Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).\n","termDef":{"term":"American Joint Committee on Cancer Metastasis Stage Code","source":"caDSR","cde_id":3045439,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3045439&version=1.0"}},"ajcc_pathologic_n":{"description":"The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.\n","termDef":{"term":"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","source":"caDSR","cde_id":3203106,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3203106&version=1.0"}},"ajcc_pathologic_stage":{"description":"The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.\n","termDef":{"term":"Neoplasm Disease Stage American Joint Committee on Cancer Code","source":"caDSR","cde_id":3203222,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3203222&version=1.0"}},"ajcc_pathologic_t":{"description":"Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).\n","termDef":{"term":"American Joint Committee on Cancer Tumor Stage Code","source":"caDSR","cde_id":3045435,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3045435&version=1.0"}},"alcohol_history":{"description":"A response to a question that asks whether the participant has consumed at least 12 drinks of any kind of alcoholic beverage in their lifetime.\n","termDef":{"term":"Alcohol Lifetime History Indicator","source":"caDSR","cde_id":2201918,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2201918&version=1.0"}},"alcohol_intensity":{"description":"Category to describe the patient's current level of alcohol use as self-reported by the patient.\n","termDef":{"term":"Person Self-Report Alcoholic Beverage Exposure Category","source":"caDSR","cde_id":3457767,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3457767&version=1.0"}},"aliquot_quantity":{"description":"The quantity in micrograms (ug) of the aliquot(s) derived from the analyte(s) shipped for sequencing and characterization.\n","termDef":{"term":"Biospecimen Aliquot Quantity","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"aliquot_volume":{"description":"The volume in microliters (ul) of the aliquot(s) derived from the analyte(s) shipped for sequencing and characterization.\n","termDef":{"term":"Biospecimen Aliquot Volume","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"amount":{"description":"Weight in grams or volume in mL.\n"},"analyte_quantity":{"description":"The quantity in micrograms (ug) of the analyte(s) derived from the analyte(s) shipped for sequencing and characterization.\n","termDef":{"term":"Biospecimen Analyte Quantity","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"analyte_type":{"description":"Text term that represents the kind of molecular specimen analyte.\n","termDef":{"term":"Molecular Specimen Type Text Name","source":"caDSR","cde_id":2513915,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2513915&version=2.0"}},"analyte_type_id":{"description":"A single letter code used to identify a type of molecular analyte.\n","termDef":{"term":"Molecular Analyte Identification Code","source":"caDSR","cde_id":5432508,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432508&version=1.0"}},"analyte_volume":{"description":"The volume in microliters (ml) of the analyte(s) derived from the analyte(s) shipped for sequencing and characterization.\n","termDef":{"term":"Biospecimen Analyte Volume","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"ann_arbor_b_symptoms":{"description":"Text term to signify whether lymphoma B-symptoms are present as noted in the patient's medical record.\n","termDef":{"term":"Lymphoma B-Symptoms Medical Record Documented Indicator","source":"caDSR","cde_id":2902402,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2902402&version=1.0"}},"ann_arbor_clinical_stage":{"description":"The classification of the clinically confirmed anatomic disease extent of lymphoma (Hodgkin's and Non-Hodgkins) based on the Ann Arbor Staging System.\n","termDef":{"term":"Ann Arbor Clinical Stage","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"ann_arbor_extranodal_involvement":{"description":"Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.\n","termDef":{"term":"Lymphomatous Extranodal Site Involvement Indicator","source":"caDSR","cde_id":3364582,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3364582&version=1.0"}},"ann_arbor_pathologic_stage":{"description":"The classification of the pathologically confirmed anatomic disease extent of lymphoma (Hodgkin's and Non-Hodgkins) based on the Ann Arbor Staging System.\n","termDef":{"term":"Ann Arbor Pathologic Stage","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"ann_arbor_tumor_stage":{"description":"The classification of the anatomic disease extent of lymphoma (Hodgkin's and Non-Hodgkins) based on the Ann Arbor Staging System.\n","termDef":{"term":"Ann Arbor Tumor Stage","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"assay_instrument":{"description":"The specific instrument type used to perform the assay. If applicable, please also indicate the instrument mode and model in 'assay_instrument_mode' and 'assay_instrument_model'."},"assay_instrument_mode":{"description":"The specific mode an instrument was run in (e.g., High Sensitivity). Please, also indicate the instrument and model in 'assay_instrument' and 'assay_instrument_model'."},"assay_instrument_model":{"description":"The specific model of instrument used to perform the assay. Please also indicate the instrument and mode in 'assay_instrument' and 'assay_instrument_mode'."},"assay_kit_name":{"description":"The name of the kit used for the test or assay; please also indicate the kit vendor and version in 'assay_kit_vendor' and 'assay_kit_version'."},"assay_kit_vendor":{"description":"The name of the vendor or manufacturer of the kit used for the test; please also indicate the kit name and version in 'assay_kit_name' and 'assay_kit_version'."},"assay_kit_version":{"description":"The version of the kit used for the test; please also indicate the kit name and vendor in 'assay_kit_name' and 'assay_kit_vendor'."},"assay_method":{"description":"General methodology used to perform the assay."},"assay_target":{"description":"Target for the assay: can be a specific gene, protein, or otherwise."},"base_caller_name":{"description":"Name of the base caller.\n"},"base_caller_version":{"description":"Version of the base caller.\n"},"biomarker_name":{"description":"The name of the biomarker being tested for this specimen and set of test results.\n","termDef":{"term":"Biomarker Name","source":"caDSR","cde_id":5473,"cde_version":11,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5473&version=2.31"}},"biomarker_result":{"description":"Text term to define the results of genetic testing.\n","termDef":{"term":"Laboratory Procedure Genetic Abnormality Test Result Type","source":"caDSR","cde_id":3234680,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3234680&version=1.0"}},"biomarker_test_method":{"description":"Text descriptor of a molecular analysis method used for an individual.\n","termDef":{"term":"Disease Detection Molecular Analysis Method Type","source":"caDSR","cde_id":3121575,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3121575&version=1.0"}},"biospecimen_anatomic_site":{"description":"Text term that represents the name of the primary disease site of the submitted tumor sample.\n","termDef":{"term":"Submitted Tumor Sample Primary Anatomic Site","source":"caDSR","cde_id":4742851,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=4742851&version=1.0"}},"bmi":{"description":"The body mass divided by the square of the body height expressed in units of kg/m^2.\n","termDef":{"term":"Body Mass Index (BMI)","source":"caDSR","cde_id":4973892,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=4973892&version=1.0"}},"burkitt_lymphoma_clinical_variant":{"description":"Burkitt's lymphoma categorization based on clinical features that differ from other forms of the same disease.\n","termDef":{"term":"Burkitt Lymphoma Clinical Variant Type","source":"caDSR","cde_id":3770421,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3770421&version=1.0"}},"cause_of_death":{"description":"Text term to identify the cause of death for a patient.\n","termDef":{"term":"Patient Death Reason","source":"caDSR","cde_id":2554674,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2554674&version=3.0"}},"cea_level_preoperative":{"description":"Numeric value of the Carcinoembryonic antigen or CEA at the time before surgery. [Manually- curated]\n","termDef":{"term":"Preoperative Carcinoembryonic Antigen Result Value","source":"caDSR","cde_id":2716510,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2716510&version=1.0"}},"cigarettes_per_day":{"description":"The average number of cigarettes smoked per day.\n","termDef":{"term":"Smoking Use Average Number","source":"caDSR","cde_id":2001716,"cde_version":4,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2001716&version=4.0"}},"circumferential_resection_margin":{"description":"A value in millimeters indicating the measured length between a malignant lesion of the colon or rectum and the nearest radial (or circumferential) border of tissue removed during cancer surgery.\n","termDef":{"term":"Colorectal Surgical Margin Circumferential Distance Measurement","source":"caDSR","cde_id":64202,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=64202&version=3.0"}},"classification_of_tumor":{"description":"Text that describes the kind of disease present in the tumor specimen as related to a specific timepoint.\n","termDef":{"term":"Tumor Tissue Disease Description Type","source":"caDSR","cde_id":3288124,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3288124&version=1.0"}},"colon_polyps_history":{"description":"Yes/No indicator to describe if the subject had a previous history of colon polyps as noted in the history/physical or previous endoscopic report (s).\n","termDef":{"term":"Colon Carcinoma Polyp Occurrence Indicator","source":"caDSR","cde_id":3107197,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3107197&version=1.0"}},"composition":{"description":"Text term that represents the cellular composition of the sample.\n","termDef":{"term":"Biospecimen Cellular Composition Type","source":"caDSR","cde_id":5432591,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432591&version=1.0"}},"concentration":{"description":"Numeric value that represents the concentration of an analyte or aliquot extracted from the sample or sample portion, measured in milligrams per milliliter.\n","termDef":{"term":"Biospecimen Analyte or Aliquot Extracted Concentration Milligram per Milliliter Value","source":"caDSR","cde_id":5432594,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432594&version=1.0"}},"creation_datetime":{"description":"The datetime of portion creation encoded as seconds from epoch.\n","termDef":{"term":"Biospecimen Portion Creation Seconds Date/Time","source":"caDSR","cde_id":5432592,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432592&version=1.0"}},"current_weight":{"description":"Numeric value that represents the current weight of the sample, measured  in milligrams.\n","termDef":{"term":"Tissue Sample Current Weight Milligram Value","source":"caDSR","cde_id":5432606,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432606&version=1.0"}},"data_category":{"description":"Broad categorization of the contents of the data file.\n"},"data_file_error_type":{"description":"Type of error for the data file object.\n"},"data_format":{"description":"Format of the data files.\n"},"data_type":{"description":"Specific content type of the data file.\n"},"datetime":{"description":"A combination of date and time of day in the form [-]CCYY-MM-DDThh:mm:ss[Z|(+|-)hh:mm]\n"},"days_to_birth":{"description":"Time interval from a person's date of birth to the date of index, represented as a calculated negative number of days.\n","termDef":{"term":"Person Birth Date Less Initial Pathologic Diagnosis Date Calculated Day Value","source":"caDSR","cde_id":3008233,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3008233&version=1.0"}},"days_to_collection":{"description":"Time interval from the date of biospecimen collection to the date of initial pathologic diagnosis, represented as a calculated number of days.\n","termDef":{"term":"Biospecimen Collection Date Less Initial Pathologic Diagnosis Date Calculated Day Value","source":"caDSR","cde_id":3008340,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3008340&version=1.0"}},"days_to_death":{"description":"Time interval from a person's date of death to the date of index, represented as a calculated number of days.\n","termDef":{"term":"Death Less Initial Pathologic Diagnosis Date Calculated Day Value","source":"caDSR","cde_id":3165475,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3165475&version=1.0"}},"days_to_hiv_diagnosis":{"description":"Time interval from the date of the index to the date of human immunodeficiency diagnosis, represented as a calculated number of days.\n","termDef":{"term":"Human Immunodeficiency Virus Diagnosis Subtract Initial Pathologic Diagnosis Time Duration Day Calculation Value","source":"caDSR","cde_id":4618491,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=4618491&version=1.0"}},"days_to_last_follow_up":{"description":"Time interval from the date of last follow up to the date of index, represented as a calculated number of days.\n","termDef":{"term":"Last Communication Contact Less Initial Pathologic Diagnosis Date Calculated Day Value","source":"caDSR","cde_id":3008273,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3008273&version=1.0"}},"days_to_last_known_disease_status":{"description":"Time interval from the date of last follow up to the date of index, represented as a calculated number of days.\n","termDef":{"term":"Last Communication Contact Less Initial Pathologic Diagnosis Date Calculated Day Value","source":"caDSR","cde_id":3008273,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3008273&version=1.0"}},"days_to_new_event":{"description":"Time interval from the date of new tumor event including progression, recurrence and new primary malignacies to the date of index, represented as a calculated number of days.\n","termDef":{"term":"New Tumor Event Less Initial Pathologic Diagnosis Date Calculated Day Value","source":"caDSR","cde_id":3392464,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3392464&version=1.0"}},"days_to_recurrence":{"description":"Time interval from the date of new tumor event including progression, recurrence and new primary malignancies to the date of index, represented as a calculated number of days.\n","termDef":{"term":"New Tumor Event Less Initial Pathologic Diagnosis Date Calculated Day Value","source":"caDSR","cde_id":3392464,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3392464&version=1.0"}},"days_to_sample_procurement":{"description":"The number of days from the date the patient was diagnosed to the date of the procedure that produced the sample.\n"},"days_to_treatment":{"description":"Number of days from date of index that treatment began.\n","termDef":{"term":"Days to Treatment Start","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"days_to_treatment_end":{"description":"Time interval from the date of the index to the date of treatment end, represented as a calculated number of days.\n","termDef":{"term":"Treatment End Subtract First Pathologic Diagnosis Day Calculation Value","source":"caDSR","cde_id":5102431,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5102431&version=1.0"}},"days_to_treatment_start":{"description":"Time interval from the date of the index to the start of treatment, represented as a calculated number of days.\n","termDef":{"term":"Treatment Start Subtract First Pathologic Diagnosis Time Day Calculation Value","source":"caDSR","cde_id":5102411,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5102411&version=1.0"}},"diagnosis_pathologically_confirmed":{"description":"The histologic description of tissue or cells confirmed by a pathology review of frozen or formalin fixed slide(s) completed after the diagnostic pathology review of the tumor sample used to extract analyte(s).\n","termDef":{"term":"Post-Diagnostic Pathology Review Confirmation","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"dlco_ref_predictive_percent":{"description":"The value, as a percentage of predicted lung volume, measuring the amount of carbon monoxide detected in a patient's lungs.\n","termDef":{"term":"Lung Carbon Monoxide Diffusing Capability Test Assessment Predictive Value Percentage Value","source":"caDSR","cde_id":2180255,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2180255&version=1.0"}},"encoding":{"description":"Version of ASCII encoding of quality values found in the file.\n","termDef":{"term":"Encoding","source":"FastQC","cde_id":null,"cde_version":null,"term_url":"http://www.bioinformatics.babraham.ac.uk/projects/fastqc/Help/3%20Analysis%20Modules/1%20Basic%20Statistics.html"}},"equipment_manufacturer":{"description":"The name of the manufacturer of the equipment used for the test; please also indicate the model number in 'equipment_model'."},"equipment_model":{"description":"The equipment name and model number used for the test; please also indicate the manufacturer name in 'equipment_manufacturer'."},"estrogen_receptor_percent_positive_ihc":{"description":"Classification to represent ER Positive results expressed as a percentage value.\n","termDef":{"term":"ER Level Cell Percentage Category","source":"caDSR","cde_id":3128341,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3128341&version=1.0"}},"estrogen_receptor_result_ihc":{"description":"Text term to represent the overall result of Estrogen Receptor (ER) testing.\n","termDef":{"term":"Breast Carcinoma Estrogen Receptor Status","source":"caDSR","cde_id":2957359,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2957359&version=2.0"}},"ethnicity":{"description":"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.\n","termDef":{"term":"Ethnic Group Category Text","source":"caDSR","cde_id":2192217,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2192217&version=2.0"}},"experiment_name":{"description":"Submitter-defined name for the experiment.\n"},"experimental_strategy":{"description":"The experimental strategy used to generate the data file.\n"},"fastq_name":{"description":"Names of FASTQs.\n"},"fev1_ref_post_bronch_percent":{"description":"The percentage comparison to a normal value reference range of the volume of air that a patient can forcibly exhale from the lungs in one second post-bronchodilator.\n","termDef":{"term":"Post Bronchodilator Lung Forced Expiratory Volume 1 Test Lab Percentage Value","source":"caDSR","cde_id":3302948,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3302948&version=1.0"}},"fev1_ref_pre_bronch_percent":{"description":"The percentage comparison to a normal value reference range of the volume of air that a patient can forcibly exhale from the lungs in one second pre-bronchodilator.\n","termDef":{"term":"Pre Bronchodilator Lung Forced Expiratory Volume 1 Test Lab Percentage Value","source":"caDSR","cde_id":3302947,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3302947&version=1.0"}},"fev1_fvc_post_bronch_percent":{"description":"Percentage value to represent result of Forced Expiratory Volume in 1 second (FEV1) divided by the Forced Vital Capacity (FVC) post-bronchodilator.\n","termDef":{"term":"Post Bronchodilator FEV1/FVC Percent Value","source":"caDSR","cde_id":3302956,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3302956&version=1.0"}},"fev1_fvc_pre_bronch_percent":{"description":"Percentage value to represent result of Forced Expiratory Volume in 1 second (FEV1) divided by the Forced Vital Capacity (FVC) pre-bronchodilator.\n","termDef":{"term":"Pre Bronchodilator FEV1/FVC Percent Value","source":"caDSR","cde_id":3302955,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3302955&version=1.0"}},"figo_stage":{"description":"The extent of a cervical or endometrial cancer within the body, especially whether the disease has spread from the original site to other parts of the body, as described by the International Federation of Gynecology and Obstetrics (FIGO) stages.\n","termDef":{"term":"Gynecologic Tumor Grouping Cervical Endometrial FIGO 2009 Stage","source":"caDSR","cde_id":3225684,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3225684&version=1.0"}},"file_name":{"description":"The name (or part of a name) of a file (of any type).\n"},"file_size":{"description":"The size of the data file (object) in bytes.\n"},"file_state":{"description":"The current state of the data file object.\n"},"flow_cell_barcode":{"description":"Flow Cell Barcode.\n"},"freezing_method":{"description":"Text term that represents the method used for freezing the sample.\n","termDef":{"term":"Tissue Sample Freezing Method Type","source":"caDSR","cde_id":5432607,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432607&version=1.0"}},"gender":{"description":"Text designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. [Explanatory Comment 1: Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.]\n","termDef":{"term":"Person Gender Text Type","source":"caDSR","cde_id":2200604,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2200604&version=3.0"}},"height":{"description":"The height of the patient in centimeters.\n","termDef":{"term":"Patient Height Measurement","source":"caDSR","cde_id":649,"cde_version":4.1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=649&version=4.1"}},"her2_erbb2_percent_positive_ihc":{"description":"Classification to represent the number of positive HER2/ERBB2 cells in a specimen or sample.\n","termDef":{"term":"HER2 ERBB Positive Finding Cell Percentage Category","source":"caDSR","cde_id":3086980,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3086980&version=1.0"}},"her2_erbb2_result_fish":{"description":"the type of outcome for HER2 as determined by an in situ hybridization (ISH) assay.\n","termDef":{"term":"Laboratory Procedure HER2/neu in situ Hybridization Outcome Type","source":"caDSR","cde_id":2854089,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2854089&version=1.0"}},"her2_erbb2_result_ihc":{"description":"Text term to signify the result of the medical procedure that involves testing a sample of blood or tissue for HER2 by histochemical localization of immunoreactive substances using labeled antibodies as reagents.\n","termDef":{"term":"Laboratory Procedure HER2/neu Immunohistochemistry Receptor Status","source":"caDSR","cde_id":2957563,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2957563&version=2.0"}},"hiv_positive":{"description":"Text term to signify whether a physician has diagnosed HIV infection in a patient.\n","termDef":{"term":"Physician Diagnosed HIV Infection Personal Medical History Yes No Not Applicable Indicator","source":"caDSR","cde_id":4030799,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=4030799&version=1.0"}},"hpv_positive_type":{"description":"Text classification to represent the strain or type of human papillomavirus identified in an individual.\n","termDef":{"term":"Human Papillomavirus Type","source":"caDSR","cde_id":2922649,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2922649&version=1.0"}},"hpv_status":{"description":"The findings of the oncogenic HPV.\n","termDef":{"term":"Oncogenic Human Papillomavirus Result Type","source":"caDSR","cde_id":2230033,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2230033&version=1.0"}},"includes_spike_ins":{"description":"Spike-in included?\n"},"initial_weight":{"description":"Numeric value that represents the initial weight of the sample, measured in milligrams.\n","termDef":{"term":"Tissue Sample Initial Weight Milligram Value","source":"caDSR","cde_id":5432605,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432605&version=1.0"}},"instrument_model":{"description":"Numeric value that represents the sample dimension that is greater than the shortest dimension and less than the longest dimension, measured in millimeters.\n","termDef":{"term":"Tissue Sample Intermediate Dimension Millimeter Measurement","source":"caDSR","cde_id":5432604,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432604&version=1.0"}},"intermediate_dimension":{"description":"Intermediate dimension of the sample, in millimeters.\n"},"is_ffpe":{"description":"Indicator to signify whether or not the tissue sample was fixed in formalin and embedded in paraffin (FFPE).\n","termDef":{"term":"Specimen Processing Formalin Fixed Paraffin Embedded Tissue Indicator","source":"caDSR","cde_id":4170557,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=4170557&version=1.0"}},"is_paired_end":{"description":"Are the reads paired end?\n"},"last_known_disease_status":{"description":"Text term that describes the last known state or condition of an individual's neoplasm.\n","termDef":{"term":"Person Last Known Neoplasm Status","source":"caDSR","cde_id":5424231,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2759550&version=1.0"}},"laterality":{"description":"For tumors in paired organs, designates the side on which the cancer originates.\n","termDef":{"term":"Primary Tumor Laterality","source":"caDSR","cde_id":827,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=827&version=3.0"}},"ldh_level_at_diagnosis":{"description":"The 2 decimal place numeric laboratory value measured, assigned or computed related to the assessment of lactate dehydrogenase in a specimen.\n","termDef":{"term":"Laboratory Procedure Lactate Dehydrogenase Result Integer::2 Decimal Place Value","source":"caDSR","cde_id":2798766,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2798766&version=1.0"}},"ldh_normal_range_upper":{"description":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for lactate dehydrogenase (units not specified).\n","termDef":{"term":"Laboratory Procedure Lactate Dehydrogenase Result Upper Limit of Normal Value","source":"caDSR","cde_id":2597015,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2597015&version=1.0"}},"library_strategy":{"description":"Library strategy.\n"},"library_selection":{"description":"Library Selection Method\n"},"library_name":{"description":"Name of the library.\n"},"library_preparation_kit_name":{"description":"Name of Library Preparation Kit\n"},"library_preparation_kit_vendor":{"description":"Vendor of Library Preparation Kit\n"},"library_preparation_kit_catalog_number":{"description":"Catalog of Library Preparation Kit\n"},"library_preparation_kit_version":{"description":"Version of Library Preparation Kit\n"},"library_strand":{"description":"Library stranded-ness.\n"},"longest_dimension":{"description":"Numeric value that represents the longest dimension of the sample, measured in millimeters.\n","termDef":{"term":"Tissue Sample Longest Dimension Millimeter Measurement","source":"caDSR","cde_id":5432602,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432602&version=1.0"}},"lymph_nodes_positive":{"description":"The number of lymph nodes involved with disease as determined by pathologic examination.\n","termDef":{"term":"Lymph Node(s) Positive Number","source":"caDSR","cde_id":89,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=89&version=3.0"}},"lymphatic_invasion_present":{"description":"A yes/no indicator to ask if small or thin-walled vessel invasion is present, indicating lymphatic involvement\n","termDef":{"term":"Lymphatic/Small vessel Invasion Ind","source":"caDSR","cde_id":64171,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=64171&version=3.0"}},"method_of_diagnosis":{"description":"The method used to initially the patient's diagnosis.\n","termDef":{"term":"Method of Diagnosis","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"method_of_sample_procurement":{"description":"The method used to procure the sample used to extract analyte(s).\n","termDef":{"term":"Method of Sample Procurement","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"md5sum":{"description":"The 128-bit hash value expressed as a 32 digit hexadecimal number used as a file's digital fingerprint.\n"},"microsatellite_instability_abnormal":{"description":"The yes/no indicator to signify the status of a tumor for microsatellite instability.\n","termDef":{"term":"Microsatellite Instability Occurrence Indicator","source":"caDSR","cde_id":3123142,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3123142&version=1.0"}},"morphology":{"description":"The third edition of the International Classification of Diseases for Oncology, published in 2000 used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms. The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs. In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains. A system of numbered categories for representation of data.\n","termDef":{"term":"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","source":"caDSR","cde_id":3226275,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3226275&version=1.0"}},"new_event_anatomic_site":{"description":"Text term to specify the anatomic location of the return of tumor after treatment.\n","termDef":{"term":"New Neoplasm Event Occurrence Anatomic Site","source":"caDSR","cde_id":3108271,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3108271&version=2.0"}},"new_event_type":{"description":"Text term to identify a new tumor event.\n","termDef":{"term":"New Neoplasm Event Type","source":"caDSR","cde_id":3119721,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3119721&version=1.0"}},"normal_tumor_genotype_snp_match":{"description":"Text term that represents whether or not the genotype of the normal tumor matches or if the data is not available.\n","termDef":{"term":"Normal Tumor Genotype Match Indicator","source":"caDSR","cde_id":4588156,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=4588156&version=1.0"}},"number_proliferating_cells":{"description":"Numeric value that represents the count of proliferating cells determined during pathologic review of the sample slide(s).\n","termDef":{"term":"Pathology Review Slide Proliferating Cell Count","source":"caDSR","cde_id":5432636,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432636&version=1.0"}},"object_id":{"description":"The GUID of the object in the index service."},"oct_embedded":{"description":"Indicator of whether or not the sample was embedded in Optimal Cutting Temperature (OCT) compound.\n","termDef":{"term":"Tissue Sample Optimal Cutting Temperature Compound Embedding Indicator","source":"caDSR","cde_id":5432538,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432538&version=1.0"}},"pack_years_smoked":{"description":"Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.\n","termDef":{"term":"Person Cigarette Smoking History Pack Year Value","source":"caDSR","cde_id":2955385,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2955385&version=1.0"}},"percent_eosinophil_infiltration":{"description":"Numeric value to represent the percentage of infiltration by eosinophils in a tumor sample or specimen.\n","termDef":{"term":"Specimen Eosinophilia Percentage Value","source":"caDSR","cde_id":2897700,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2897700&version=2.0"}},"percent_gc_content":{"description":"The overall %GC of all bases in all sequences.\n","termDef":{"term":"%GC","source":"FastQC","cde_id":null,"cde_version":null,"term_url":"http://www.bioinformatics.babraham.ac.uk/projects/fastqc/Help/3%20Analysis%20Modules/1%20Basic%20Statistics.html"}},"percent_granulocyte_infiltration":{"description":"Numeric value to represent the percentage of infiltration by granulocytes in a tumor sample or specimen.\n","termDef":{"term":"Specimen Granulocyte Infiltration Percentage Value","source":"caDSR","cde_id":2897705,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2897705&version=2.0"}},"percent_inflam_infiltration":{"description":"Numeric value to represent local response to cellular injury, marked by capillary dilatation, edema and leukocyte infiltration; clinically, inflammation is manifest by reddness, heat, pain, swelling and loss of function, with the need to heal damaged tissue.\n","termDef":{"term":"Specimen Inflammation Change Percentage Value","source":"caDSR","cde_id":2897695,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2897695&version=1.0"}},"percent_lymphocyte_infiltration":{"description":"Numeric value to represent the percentage of infiltration by lymphocytes in a solid tissue normal sample or specimen.\n","termDef":{"term":"Specimen Lymphocyte Infiltration Percentage Value","source":"caDSR","cde_id":2897710,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2897710&version=2.0"}},"percent_monocyte_infiltration":{"description":"Numeric value to represent the percentage of monocyte infiltration in a sample or specimen.\n","termDef":{"term":"Specimen Monocyte Infiltration Percentage Value","source":"caDSR","cde_id":5455535,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5455535&version=1.0"}},"percent_necrosis":{"description":"Numeric value to represent the percentage of cell death in a malignant tumor sample or specimen.\n","termDef":{"term":"Malignant Neoplasm Necrosis Percentage Value","source":"caDSR","cde_id":2841237,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2841237&version=1.0"}},"percent_neutrophil_infiltration":{"description":"Numeric value to represent the percentage of infiltration by neutrophils in a tumor sample or specimen.\n","termDef":{"term":"Malignant Neoplasm Neutrophil Infiltration Percentage Cell Value","source":"caDSR","cde_id":2841267,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2841267&version=1.0"}},"percent_normal_cells":{"description":"Numeric value to represent the percentage of normal cell content in a malignant tumor sample or specimen.\n","termDef":{"term":"Malignant Neoplasm Normal Cell Percentage Value","source":"caDSR","cde_id":2841233,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2841233&version=1.0"}},"percent_stromal_cells":{"description":"Numeric value to represent the percentage of reactive cells that are present in a malignant tumor sample or specimen but are not malignant such as fibroblasts, vascular structures, etc.\n","termDef":{"term":"Malignant Neoplasm Stromal Cell Percentage Value","source":"caDSR","cde_id":2841241,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2841241&version=1.0"}},"percent_tumor_cells":{"description":"Numeric value that represents the percentage of infiltration by granulocytes in a sample.\n","termDef":{"term":"Specimen Tumor Cell Percentage Value","source":"caDSR","cde_id":5432686,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432686&version=1.0"}},"percent_tumor_nuclei":{"description":"Numeric value to represent the percentage of tumor nuclei in a malignant neoplasm sample or specimen.\n","termDef":{"term":"Malignant Neoplasm Neoplasm Nucleus Percentage Cell Value","source":"caDSR","cde_id":2841225,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2841225&version=1.0"}},"perineural_invasion_present":{"description":"a yes/no indicator to ask if perineural invasion or infiltration of tumor or cancer is present.\n","termDef":{"term":"Tumor Perineural Invasion Ind","source":"caDSR","cde_id":64181,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=64181&version=3.0"}},"platform":{"description":"Name of the platform used to obtain data.\n"},"portion_number":{"description":"Numeric value that represents the sequential number assigned to a portion of the sample.\n","termDef":{"term":"Biospecimen Portion Sequence Number","source":"caDSR","cde_id":5432711,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432711&version=1.0"}},"portion_weight":{"description":"Numeric value that represents the sample portion weight, measured in milligrams.\n","termDef":{"term":"Biospecimen Portion Weight Milligram Value","source":"caDSR","cde_id":5432593,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432593&version=1.0"}},"preservation_method":{"description":"Text term that represents the method used to preserve the sample.\n","termDef":{"term":"Tissue Sample Preservation Method Type","source":"caDSR","cde_id":5432521,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432521&version=1.0"}},"primary_diagnosis":{"description":"Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.\n","termDef":{"term":"Neoplasm Histologic Type Name","source":"caDSR","cde_id":3081934,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3081934&version=3.0"}},"prior_malignancy":{"description":"Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.\n","termDef":{"term":"Prior Cancer Diagnosis Occurrence Description Text","source":"caDSR","cde_id":3382736,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3382736&version=2.0"}},"prior_treatment":{"description":"A yes/no/unknown/not applicable indicator related to the administration of therapeutic agents received before the body specimen was collected.\n","termDef":{"term":"Therapeutic Procedure Prior Specimen Collection Administered Yes No Unknown Not Applicable Indicator","source":"caDSR","cde_id":4231463,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=4231463&version=1.0"}},"progesterone_receptor_percent_positive_ihc":{"description":"Classification to represent Progesterone Receptor Positive results expressed as a percentage value.\n","termDef":{"term":"Progesterone Receptor Level Cell Percentage Category","source":"caDSR","cde_id":3128342,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3128342&version=1.0"}},"progesterone_receptor_result_ihc":{"description":"Text term to represent the overall result of Progresterone Receptor (PR) testing.\n","termDef":{"term":"Breast Carcinoma Progesterone Receptor Status","source":"caDSR","cde_id":2957357,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2957357&version=2.0"}},"progression_or_recurrence":{"description":"Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.\n","termDef":{"term":"New Neoplasm Event Post Initial Therapy Indicator","source":"caDSR","cde_id":3121376,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3121376&version=1.0"}},"project_id":{"description":"Unique ID for any specific defined piece of work that is undertaken or attempted to meet a single requirement.\n"},"qc_metric_state":{"description":"State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.\n","termDef":{"term":"QC Metric State","source":"FastQC","cde_id":null,"cde_version":null,"term_url":"http://www.bioinformatics.babraham.ac.uk/projects/fastqc/Help/3%20Analysis%20Modules/"}},"race":{"description":"An arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.\n","termDef":{"term":"Race Category Text","source":"caDSR","cde_id":2192199,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2192199&version=1.0"}},"read_length":{"description":"The length of the reads.\n"},"read_group_name":{"description":"The name of the read group.\n"},"relationship_age_at_diagnosis":{"description":"The age (in years) when the patient's relative was first diagnosed; if age is greater than 89 years, use 'relationship_age_at_diagnosis_gt89'.\n","termDef":{"term":"Relative Diagnosis Age Value","source":"caDSR","cde_id":5300571,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5300571&version=1.0"}},"relationship_age_at_diagnosis_gt89":{"description":"Indicate whether the age (in years) when the patient's relative was first diagnosed is greater than 89 years.\n","termDef":{"term":"Relative Diagnosis Age Value","source":"caDSR","cde_id":5300571,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5300571&version=1.0"}},"relationship_type":{"description":"The subgroup that describes the state of connectedness between members of the unit of society organized around kinship ties.\n","termDef":{"term":"Family Member Relationship Type","source":"caDSR","cde_id":2690165,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2690165&version=2.0"}},"relative_with_cancer_history":{"description":"Indicator to signify whether or not an individual's biological relative has been diagnosed with another type of cancer.\n","termDef":{"term":"Other Cancer Biological Relative History Indicator","source":"caDSR","cde_id":3901752,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3901752&version=1.0"}},"residual_disease":{"description":"Text terms to describe the status of a tissue margin following surgical resection.\n","termDef":{"term":"Surgical Margin Resection Status","source":"caDSR","cde_id":2608702,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2608702&version=1.0"}},"RIN":{"description":"A numerical assessment of the integrity of RNA based on the entire electrophoretic trace of the RNA sample including the presence or absence of degradation products.\n","termDef":{"term":"Biospecimen RNA Integrity Number Value","source":"caDSR","cde_id":5278775,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5278775&version=1.0"}},"sample_type":{"description":"Text term to describe the source of a biospecimen used for a laboratory test.\n","termDef":{"term":"Specimen Type Collection Biospecimen Type","source":"caDSR","cde_id":3111302,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3111302&version=2.0"}},"sample_type_id":{"description":"The accompanying sample type id for the sample type.\n"},"section_location":{"description":"Tissue source of the slide.\n"},"sequencing_center":{"description":"Name of the center that provided the sequence files.\n"},"shortest_dimension":{"description":"Numeric value that represents the shortest dimension of the sample, measured in millimeters.\n","termDef":{"term":"Tissue Sample Short Dimension Millimeter Measurement","source":"caDSR","cde_id":5432603,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432603&version=1.0"}},"site_of_resection_or_biopsy":{"description":"The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms. The description of an anatomical region or of a body part. Named locations of, or within, the body. A system of numbered categories for representation of data.\n","termDef":{"term":"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","source":"caDSR","cde_id":3226281,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3226281&version=1.0"}},"size_selection_range":{"description":"Range of size selection.\n"},"smoking_history":{"description":"Category describing current smoking status and smoking history as self-reported by a patient.\n","termDef":{"term":"Smoking History","source":"caDSR","cde_id":2181650,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2181650&version=1.0"}},"smoking_intensity":{"description":"Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20\n","termDef":{"term":"Person Cigarette Smoking History Pack Year Value","source":"caDSR","cde_id":2955385,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2955385&version=1.0"}},"source_center":{"description":"Name of the center that provided the item.\n"},"spectrophotometer_method":{"description":"Name of the method used to determine the concentration of purified nucleic acid within a solution.\n","termDef":{"term":"Purification Nucleic Acid Solution Concentration Determination Method Type","source":"caDSR","cde_id":3008378,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3008378&version=1.0"}},"spike_ins_fasta":{"description":"Name of the FASTA file that contains the spike-in sequences.\n"},"spike_ins_concentration":{"description":"Spike in concentration.\n"},"state":{"description":"The current state of the object.\n"},"target_capture_kit_name":{"description":"Name of Target Capture Kit.\n"},"target_capture_kit_vendor":{"description":"Vendor of Target Capture Kit.\n"},"target_capture_kit_catalog_number":{"description":"Catalog of Target Capture Kit.\n"},"target_capture_kit_version":{"description":"Version of Target Capture Kit.\n"},"target_capture_kit_target_region":{"description":"Target Capture Kit BED file.\n"},"therapeutic_agents":{"description":"Text identification of the individual agent(s) used as part of a prior treatment regimen.\n","termDef":{"term":"Prior Therapy Regimen Text","source":"caDSR","cde_id":2975232,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2975232&version=1.0"}},"time_between_clamping_and_freezing":{"description":"Numeric representation of the elapsed time between the surgical clamping of blood supply and freezing of the sample, measured in minutes.\n","termDef":{"term":"Tissue Sample Clamping and Freezing Elapsed Minute Time","source":"caDSR","cde_id":5432611,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432611&version=1.0"}},"time_between_excision_and_freezing":{"description":"Numeric representation of the elapsed time between the excision and freezing of the sample, measured in minutes.\n","termDef":{"term":"Tissue Sample Excision and Freezing Elapsed Minute Time","source":"caDSR","cde_id":5432612,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432612&version=1.0"}},"tissue_or_organ_of_origin":{"description":"Text term that describes the anatomic site of the tumor or disease.\n","termDef":{"term":"Tumor Disease Anatomic Site","source":"caDSR","cde_id":3427536,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3427536&version=3.0"}},"tissue_type":{"description":"Text term that represents a description of the kind of tissue collected with respect to disease status or proximity to tumor tissue.\n","termDef":{"term":"Tissue Sample Description Type","source":"caDSR","cde_id":5432687,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432687&version=1.0"}},"to_trim_adapter_sequence":{"description":"Does the user suggest adapter trimming?\n"},"tobacco_smoking_onset_year":{"description":"The year in which the participant began smoking.\n","termDef":{"term":"Started Smoking Year","source":"caDSR","cde_id":2228604,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2228604&version=1.0"}},"tobacco_smoking_quit_year":{"description":"The year in which the participant quit smoking.\n","termDef":{"term":"Stopped Smoking Year","source":"caDSR","cde_id":2228610,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2228610&version=1.0"}},"tobacco_smoking_status":{"description":"Category describing current smoking status and smoking history as self-reported by a patient.\n","termDef":{"term":"Patient Smoking History Category","source":"caDSR","cde_id":2181650,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2181650&version=1.0"}},"total_sequences":{"description":"A count of the total number of sequences processed.\n","termDef":{"term":"Total Sequences","source":"FastQC","cde_id":null,"cde_version":null,"term_url":"http://www.bioinformatics.babraham.ac.uk/projects/fastqc/Help/3%20Analysis%20Modules/1%20Basic%20Statistics.html"}},"treatment_anatomic_site":{"description":"The anatomic site or field targeted by a treatment regimen or single agent therapy.\n","termDef":{"term":"Treatment Anatomic Site","source":null,"cde_id":null,"cde_version":null,"term_url":null}},"treatment_intent_type":{"description":"Text term to identify the reason for the administration of a treatment regimen. [Manually-curated]\n","termDef":{"term":"Treatment Regimen Intent Type","source":"caDSR","cde_id":2793511,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2793511&version=1.0"}},"treatment_or_therapy":{"description":"A yes/no/unknown/not applicable indicator related to the administration of therapeutic agents received before the body specimen was collected.\n","termDef":{"term":"Therapeutic Procedure Prior Specimen Collection Administered Yes No Unknown Not Applicable Indicator","source":"caDSR","cde_id":4231463,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=4231463&version=1.0"}},"treatment_outcome":{"description":"Text term that describes the patient¿s final outcome after the treatment was administered.\n","termDef":{"term":"Treatment Outcome Type","source":"caDSR","cde_id":5102383,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5102383&version=1.0"}},"treatment_type":{"description":"Text term that describes the kind of treatment administered.\n","termDef":{"term":"Treatment Method Type","source":"caDSR","cde_id":5102381,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5102381&version=1.0"}},"tumor_grade":{"description":"Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.\n","termDef":{"term":"Neoplasm Histologic Grade","source":"caDSR","cde_id":2785839,"cde_version":2,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2785839&version=2.0"}},"tumor_code":{"description":"A specification of a cancer through cellular origin and localization.\n"},"tumor_code_id":{"description":"BCR-defined id code for the tumor sample.\n"},"tumor_descriptor":{"description":"Text that describes the kind of disease present in the tumor specimen as related to a specific timepoint.\n","termDef":{"term":"Tumor Tissue Disease Description Type","source":"caDSR","cde_id":3288124,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3288124&version=1.0"}},"tumor_stage":{"description":"The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body. The accepted values for tumor_stage depend on the tumor site, type, and accepted staging system. These items should accompany the tumor_stage value as associated metadata.\n","termDef":{"term":"Tumor Stage","source":"NCIt","cde_id":"C16899","cde_version":null,"term_url":"https://ncit.nci.nih.gov/ncitbrowser/pages/concept_details.jsf?dictionary=NCI%20Thesaurus&code=C16899"}},"universal_molecular_identifier":{"description":"Short sequences or barcodes added to each read for next generation sequencing protocols used to detect and quantify unique transcripts.\n"},"UUID":{"description":"A 128-bit identifier. Depending on the mechanism used to generate it, it is either guaranteed to be different from all other UUIDs/GUIDs generated until 3400 AD or extremely likely to be different. Its relatively small size lends itself well to sorting, ordering, and hashing of all sorts, storing in databases, simple allocation, and ease of programming in general.\n","termDef":{"term":"Universally Unique Identifier","source":"NCIt","cde_id":"C54100","cde_version":null,"term_url":"https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&version=16.02d&ns=NCI_Thesaurus&code=C54100"}},"vascular_invasion_present":{"description":"The yes/no indicator to ask if large vessel or venous invasion was detected by surgery or presence in a tumor specimen.\n","termDef":{"term":"Tumor Vascular Invasion Ind-3","source":"caDSR","cde_id":64358,"cde_version":3,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=64358&version=3.0"}},"vital_status":{"description":"The survival state of the person registered on the protocol.\n","termDef":{"term":"Patient Vital Status","source":"caDSR","cde_id":5,"cde_version":5,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5&version=5.0"}},"weight":{"description":"The weight of the patient measured in kilograms.\n","termDef":{"term":"Patient Weight Measurement","source":"caDSR","cde_id":651,"cde_version":4,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=651&version=4.0"}},"well_number":{"description":"Numeric value that represents the the well location within a plate for the analyte or aliquot from the sample.\n","termDef":{"term":"Biospecimen Analyte or Aliquot Plate Well Number","source":"caDSR","cde_id":5432613,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=5432613&version=1.0"}},"workflow_type":{"description":"Generic name for the workflow used to analyze a data set.\n"},"year_of_birth":{"description":"Numeric value to represent the calendar year in which an individual was born.\n","termDef":{"term":"Year Birth Date Number","source":"caDSR","cde_id":2896954,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2896954&version=1.0"}},"year_of_diagnosis":{"description":"Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.\n","termDef":{"term":"Year of initial pathologic diagnosis","source":"caDSR","cde_id":2896960,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2896960&version=1.0"}},"year_of_death":{"description":"Numeric value to represent the year of the death of an individual.\n","termDef":{"term":"Year Death Number","source":"caDSR","cde_id":2897030,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=2897030&version=1.0"}},"years_smoked":{"description":"Numeric value (or unknown) to represent the number of years a person has been smoking.\n","termDef":{"term":"Person Smoking Duration Year Count","source":"caDSR","cde_id":3137957,"cde_version":1,"term_url":"https://cdebrowser.nci.nih.gov/CDEBrowser/search?elementDetails=9&FirstTimer=0&PageId=ElementDetailsGroup&publicId=3137957&version=1.0"}}},"sample.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"sample","title":"Sample","type":"object","namespace":"https://data.bloodpac.org","category":"biospecimen","program":"*","project":"*","description":"Any part of the biological whole of the biospecimen. In the case of solid tissue, this would be a particular set of cells. In the case of fluids, such as blood, this can refer to the plasma, peripheral blood components, or any combination therein.\n","additionalProperties":false,"submittable":true,"validators":null,"systemProperties":["id","project_id","state","created_datetime","updated_datetime"],"required":["submitter_id","type","composition","biospecimens"],"uniqueKeys":[["id"],["project_id","submitter_id"]],"links":[{"name":"biospecimens","backref":"samples","label":"derived_from","target_type":"biospecimen","multiplicity":"many_to_many","required":true}],"properties":{"$ref":"_definitions.yaml#/ubiquitous_properties","blood_fractionation_method":{"description":"The name or description of the method used to obtain the blood fraction sample. (e.g. Ficoll Method, Novartis Protocol #001, 2000 g centrifuge at 4C with gentle deceleration). Alternatively, if you have provided a detailed protocol, enter its file_name here.\n","type":"string"},"composition":{"term":{"$ref":"_terms.yaml#/composition"},"enum":["Bone Marrow Components","Bone Marrow Components NOS","Buccal Cells","Buffy Coat","Control Analyte","Cell","Circulating Tumor Cell (CTC)","Derived Cell Line","EBV Immortalized","Fibroblasts from Bone Marrow Normal","Granulocytes","Human Original Cells","Lymphocytes","Mononuclear Cells from Bone Marrow Normal","Peripheral Blood Components NOS","Peripheral Blood Nucleated Cells","Peripheral Whole Blood","Plasma","Pleural Effusion","Saliva","Serum","Solid Tissue","Sputum","Unknown","Whole Bone Marrow"]},"hours_to_fractionation_lower":{"description":"The lower limit on the amount of time, in hours, between the blood draw and the fractionation into its components. If the exact time is known, make this value equal to that of the upper limit. If the time is completely unknown or if no fractionation was performed on this sample, enter the appropriate value in hours_to_fractionation_lower_other.\n","type":"number"},"hours_to_fractionation_upper":{"description":"The upper limit on the amount of time, in hours, between the blood draw and the fractionation into its components. If the exact time is known, make this value equal to that of the lower limit. If the time is completely unknown or if no fractionation was performed on this sample, enter the appropriate value in hours_to_fractionation_upper_other.\n","type":"number"},"hours_to_fractionation_lower_other":{"description":"If the lower limit on the amount of time, in hours, between the blood draw and the fractionation into its components is completely unknown or if no fractionation was performed on this sample, enter that here.\n","enum":["Not Applicable","Unknown"]},"hours_to_fractionation_upper_other":{"description":"If the upper limit on the amount of time, in hours, between the blood draw and the fractionation into its components is completely unknown or if no fractionation was performed on this sample, enter that here.\n","enum":["Not Applicable","Unknown"]},"sample_quantity":{"description":"For solid samples, the mass of the sample in milligrams (mg).","type":"number"},"sample_volume":{"description":"For liquid samples, the volume of the sample in millilitres (mL).","type":"number"},"storage_agitation_hours":{"description":"The number of hours samples were agitated during storage; if a number is given here, also answer 'Yes' to 'storage_agitation'.\n","type":"number"},"storage_agitation":{"description":"Indicate whether samples were agitated during storage.\n","enum":["Yes","No","Unknown"]},"biospecimens":{"$ref":"_definitions.yaml#/to_many"}}},"biospecimen.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"biospecimen","title":"Biospecimen","type":"object","namespace":"https://data.bloodpac.org","category":"biospecimen","program":"*","project":"*","description":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products. In the case of contrived samples, it describes any material obtained from a normal donor. Link this record to the followup node in order to record patient context variables related to blood draws or biospecimen collection.\n","additionalProperties":false,"submittable":true,"validators":null,"systemProperties":["id","project_id","state","created_datetime","updated_datetime"],"links":[{"name":"cases","backref":"biospecimens","label":"derived_from","target_type":"case","multiplicity":"many_to_one","required":true},{"name":"followups","backref":"biospecimens","label":"derived_from","target_type":"followup","multiplicity":"many_to_one","required":false}],"uniqueKeys":[["id"],["project_id","submitter_id"]],"required":["submitter_id","type","cases","biospecimen_type","biospecimen_anatomic_site","blood_tube_type","method_of_procurement","procured_or_purchased","tissue_type"],"properties":{"$ref":"_definitions.yaml#/ubiquitous_properties","biospecimen_anatomic_site":{"term":{"$ref":"_terms.yaml#/biospecimen_anatomic_site"},"enum":["Abdomen","Abdominal Wall","Acetabulum","Adenoid","Adipose","Adrenal","Alveolar Ridge","Amniotic Fluid","Ampulla of Vater","Anal Sphincter","Ankle","Anorectum","Antecubital Fossa","Antrum","Anus","Aorta","Aortic Body","Appendix","Aqueous Fluid","Arm","Artery","Ascending Colon","Ascending Colon Hepatic Flexure","Auditory Canal","Autonomic Nervous System","Axilla","Back","Bile Duct","Bladder","Blood","Blood Vessel","Bone","Bone Marrow","Bowel","Brain","Brain Stem","Breast","Broad Ligament","Bronchiole","Bronchus","Brow","Buccal Cavity","Buccal Mucosa","Buttock","Calf","Capillary","Cardia","Carina","Carotid Artery","Carotid Body","Cartilage","Cecum","Cell-Line","Central Nervous System","Cerebellum","Cerebral Cortex","Cerebrospinal Fluid","Cerebrum","Cervical Spine","Cervix","Chest","Chest Wall","Chin","Clavicle","Clitoris","Colon","Colon (Mucosa Only)","Common Duct","Conjunctiva","Connective Tissue","Dermal","Descending Colon","Diaphragm","Duodenum","Ear","Ear Canal","Ear, Pinna (External)","Effusion","Elbow","Endocrine Gland","Epididymis","Epidural Space","Esophagogastric Junction","Esophagus","Esophagus (Mucosa Only)","Eye","Fallopian Tube","Femoral Artery","Femoral Vein","Femur","Fibroblasts","Fibula","Finger","Floor of Mouth","Fluid","Foot","Forearm","Forehead","Foreskin","Frontal Cortex","Frontal Lobe","Fundus of Stomach","Gallbladder","Ganglia","Gastroesophageal Junction","Gastrointestinal Tract","Groin","Gum","Hand","Hard Palate","Head and Neck","Head (Face Or Neck) NOS","Heart","Hepatic","Hepatic Duct","Hepatic Vein","Hip","Hippocampus","Humerus","Hypopharynx","Ileum","Ilium","Index Finger","Ischium","Islet Cells","Jaw","Jejunum","Joint","Kidney","Knee","Lacrimal Gland","Large Bowel","Laryngopharynx","Larynx","Leg","Leptomeninges","Ligament","Lip","Liver","Lumbar Spine","Lung","Lymph Node","Lymph Node(s) Axilla","Lymph Node(s) Cervical","Lymph Node(s) Distant","Lymph Node(s) Epitrochlear","Lymph Node(s) Femoral","Lymph Node(s) Hilar","Lymph Node(s) Iliac-Common","Lymph Node(s) Iliac-External","Lymph Node(s) Inguinal","Lymph Node(s) Internal Mammary","Lymph Node(s) Mammary","Lymph Node(s) Mesenteric","Lymph Node(s) Occipital","Lymph Node(s) Paraaortic","Lymph Node(s) Parotid","Lymph Node(s) Pelvic","Lymph Node(s) Popliteal","Lymph Node(s) Regional","Lymph Node(s) Retroperitoneal","Lymph Node(s) Scalene","Lymph Node(s) Splenic","Lymph Node(s) Subclavicular","Lymph Node(s) Submandibular","Lymph Node(s) Supraclavicular","Lymph Nodes(s) Mediastinal","Mandible","Maxilla","Mediastinal Soft Tissue","Mediastinum","Mesentery","Mesothelium","Middle Finger","Mitochondria","Muscle","Nails","Nasal Cavity","Nasal Soft Tissue","Nasopharynx","Neck","Nerve","Nerve(s) Cranial","Occipital Cortex","Ocular Orbits","Omentum","Oral Cavity","Oral Cavity (Mucosa Only)","Oropharynx","Other","Ovary","Palate","Pancreas","Paraspinal Ganglion","Parathyroid","Parotid Gland","Patella","Pelvis","Penis","Pericardium","Periorbital Soft Tissue","Peritoneal Cavity","Peritoneum","Pharynx","Pineal","Pineal Gland","Pituitary Gland","Placenta","Pleura","Popliteal Fossa","Prostate","Pylorus","Rectosigmoid Junction","Rectum","Retina","Retro-Orbital Region","Retroperitoneum","Rib","Ring Finger","Round Ligament","Sacrum","Salivary Gland","Scalp","Scapula","Sciatic Nerve","Scrotum","Seminal Vesicle","Shoulder","Sigmoid Colon","Sinus","Sinus(es), Maxillary","Skeletal Muscle","Skin","Skull","Small Bowel","Small Bowel (Mucosa Only)","Small Finger","Soft Tissue","Spinal Column","Spinal Cord","Spleen","Splenic Flexure","Sternum","Stomach","Stomach (Mucosa Only)","Subcutaneous Tissue","Synovium","Temporal Cortex","Tendon","Testis","Thigh","Thoracic Spine","Thorax","Throat","Thumb","Thymus","Thyroid","Tibia","Tongue","Tonsil","Tonsil (Pharyngeal)","Trachea Major Bronchi","Transverse Colon","Trunk","Umbilical Cord","Ureter","Urethra","Urinary Tract","Uterus","Uvula","Vagina","Vas Deferens","Vein","Venous","Vertebra","Vulva","White Blood Cells","Wrist","Unknown"]},"biospecimen_type":{"description":"A top level description of the biospecimen. Is the biospecimen a fluid or solid tissue?\n","enum":["Fluid","Solid Tissue"]},"biospecimen_volume":{"description":"For fluid biospecimens this is the total volume in milliliters.\n","type":"number"},"biospecimen_weight":{"description":"For solid tissue biospecimens this is the total weight in milligrams.\n","type":"number"},"blood_draw_method":{"description":"The name or generalized description of the method used to draw a blood biospecimen. Alternatively, if you have provided a blood draw protocol, put the associated file_name here.\n","type":"string"},"blood_tube_type":{"description":"The kind of tube used to collect the sample(s) taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes.\n","enum":["EDTA","CellSave","Streck","Acid Citrate Dextrose (ACD)","Not Applicable","Unknown"]},"clinical_site":{"description":"The name or identifier for the clinical site at which the biospecimen was taken from the patient.\n","type":"string"},"collaboration_id":{"description":"In cases where the same biospecimen is used by multiple institutions, a deidenfitied id may provided here to tie those together. Work with your collaborators assure the same id is in all projects.\n","type":"string"},"days_to_collection":{"description":"The number of days between the index date and the date the biospecimen was received at laboratory that will be processing the biospecimen. If this value is anything other than an integer, for example, \"Unknown\", \"Not Reported\" or \"Not Applicable\", etc., record this text value in 'days_to_collection_other'.\n","type":"integer"},"days_to_collection_other":{"description":"If 'days_to_collection' is anything other than an integer, for example, \"Unknown\", \"Not Reported\" or \"Not Applicable\", etc., record that value here.\n","type":"string"},"days_to_procurement":{"description":"The number of days between the index date and the date the biospecimen was taken from the patient, such as a blood draw. If this value is anything other than an integer, for example, \"Unknown\", \"Not Reported\" or \"Not Applicable\", etc., record this text value in 'days_to_procurement_other'.\n","type":"integer"},"days_to_procurement_other":{"description":"If 'days_to_procurement' is anything other than an integer, for example, \"Unknown\", \"Not Reported\" or \"Not Applicable\", etc., record that value here.\n","type":"string"},"disease_type":{"description":"The primary disease of the patient from which the biospecimen was taken.\n","enum":["Advanced Adenoma","Blood Cancer","Breast Cancer","Colorectal Cancer","Gastric Cancer","Kidney Cancer","Liver Cancer","Lung Cancer","Melanoma","Ovarian Cancer","Pancreatic Cancer","Prostate Cancer","Sarcoma","Uterine Cancer","Healthy","Unknown"]},"metastatic_bone":{"description":"True/False indicator of whether metastasis had been confirmed in an area of bone of the patient from which the biospecimen was taken.\n","type":"boolean"},"metastatic_lymph_node":{"description":"True/False indicator of whether metastasis had been confirmed in the lymph nodes of the patient from which the biospecimen was taken.\n","type":"boolean"},"metastatic_visceral":{"description":"True/False indicator of whether metastasis had been confirmed in the viscera of the patient from which the biospecimen was taken.\n","type":"boolean"},"method_of_procurement":{"term":{"$ref":"_terms.yaml#/method_of_sample_procurement"},"enum":["Biopsy","Blood Draw","Not Applicable","Unknown"]},"primary_site":{"description":"The site of the primary tumor for the patient from which the biospecimen was taken.\n","enum":["Bone","Bone Marrow","Brain","Breast","Central Nervous System","Cervix","Colorectal","Corpus Uteri","Digestive Organs","Endocrine Gland","Esophagus","Eye","Female Genital Organs","Head and Neck","Hematopoietic System","Integumentary System","Joints and Articular Cartilage","Kidney","Liver","Lung","Lymph Node","Male Genital Organs","Other Sites","Ovary","Pancreas","Pleura","Prostate","Retroperitoneum and Peritoneum","Skin","Soft Tissue","Stomach","Testis","Thoracic Organs","Thymus","Thyroid","Unknown","Urinary System","Uterus"]},"procured_or_purchased":{"description":"Was the biospecimen purchased from a vendor or procured from a study participant.\n","enum":["Procured","Purchased"]},"procurement_temperature":{"description":"The temperature, in centigrade, at which the biospecimen was kept after procuring it from the patient. Use 20 for room temperature; 0 for on ice.\n","type":"number"},"shipping_temperature":{"description":"The temperature, in centigrade, at which the biospecimen was kept while it was being transported from the procurement site to its processing destination.\n","type":"number"},"tissue_type":{"term":{"$ref":"_terms.yaml#/tissue_type"},"enum":["Tumor","Normal","Abnormal","Peripheral Blood","Peritumoral","Unknown"]},"tumor_code":{"term":{"$ref":"_terms.yaml#/tumor_code"},"enum":["Acinar Cell Neoplasms","Adenomas and Adenocarcinomas","Adnexal and Skin Appendage Neoplasms","Basal Cell Neoplasms","Blood Vessel Tumors","Chronic Myeloproliferative Disorders","Complex Epithelial Neoplasms","Complex Mixed and Stromal Neoplasms","Cystic, Mucinous and Serous Neoplasms","Ductal and Lobular Neoplams","Epithelial Neoplasms, NOS","Fibroepithelial Neoplasms","Fibromatous Neoplasms","Germ Cell Neoplasms","Giant Cell Tumors","Gliomas","Granular Cell Tumors and Alveolar Soft Part Sarcomas","Hodgkin Lymphoma","Immunoproliferative Disease","Leukemias, NOS","Lipomatous Neoplasms","Lymphatic Vessel Tumors","Lymphoid Leukemias","Malignant Lymphomas, NOS or Diffuse","Mast Cell Tumors","Mature B-Cell Lymphomas","Mature T- and NK-Cell Lymphomas","Meningiomas","Mesonephromas","Mesothelial Neoplasms","Miscellaneous Bone Tumors","Miscellaneous Tumors","Mucoepidermoid Neoplasms","Myelodysplastic Syndromes","Myeloid Leukemias","Myomatous Neoplasms","Myxomatous Neoplasms","Neoplasms","Neoplasms of Histiocytes and Accessory Lymphoid Cells","Nerve Sheath Tumors","Neuroepitheliomatous Neoplasms","Nevi and Melanomas","Non-small Cell Carcinoma","Odontogenic Tumors","Osseous and Chondromatous Neoplasms","Other Hematologic Disorders","Other Leukemias","Paragangliomas and Glomus Tumors","Plasma Cell Tumors","Precursor Cell Lymphoblastic Lymphoma","Soft Tissue Tumors and Sarcomas, NOS","Specialized Gonadal Neoplasms","Squamous Cell Carcinoma","Squamous Cell Neoplasms","Synovial-like Neoplasms","Thymic Epithelial Neoplasms","Transitional Cell Papillomas and Carcinomas","Non Cancerous Tissue"]},"tumor_descriptor":{"term":{"$ref":"_terms.yaml#/tumor_descriptor"},"enum":["Metastatic","Not Applicable","Primary","Recurrence","Xenograft","NOS","Unknown"]},"tumor_morphology":{"description":"The specific description of the tumor morphology. Please use the ICD-0-3 code name (e.g. \"Neoplasm, benign\", \"Carcinoma, Nos\", or \"Hepatocellular adenoma\").\n","type":"string"},"cases":{"$ref":"_definitions.yaml#/to_one"},"followups":{"$ref":"_definitions.yaml#/to_one"}}},"_definitions.yaml":{"id":"_definitions","UUID":{"term":{"$ref":"_terms.yaml#/UUID"},"type":"string","pattern":"^[a-fA-F0-9]{8}-[a-fA-F0-9]{4}-[a-fA-F0-9]{4}-[a-fA-F0-9]{4}-[a-fA-F0-9]{12}$"},"parent_uuids":{"type":"array","minItems":1,"items":{"$ref":"#/UUID"},"uniqueItems":true},"foreign_key_project":{"type":"object","additionalProperties":true,"properties":{"id":{"$ref":"#/UUID"},"code":{"type":"string"}}},"to_one_project":{"anyOf":[{"type":"array","items":{"$ref":"#/foreign_key_project","minItems":1,"maxItems":1}},{"$ref":"#/foreign_key_project"}]},"to_many_project":{"anyOf":[{"type":"array","items":{"$ref":"#/foreign_key_project","minItems":1}},{"$ref":"#/foreign_key_project"}]},"foreign_key":{"type":"object","additionalProperties":true,"properties":{"id":{"$ref":"#/UUID"},"submitter_id":{"type":"string"}}},"to_one":{"anyOf":[{"type":"array","items":{"$ref":"#/foreign_key","minItems":1,"maxItems":1}},{"$ref":"#/foreign_key"}]},"to_many":{"anyOf":[{"type":"array","items":{"$ref":"#/foreign_key","minItems":1}},{"$ref":"#/foreign_key"}]},"datetime":{"oneOf":[{"type":"string","format":"date-time"},{"type":"null"}],"term":{"$ref":"_terms.yaml#/datetime"}},"file_name":{"type":"string","term":{"$ref":"_terms.yaml#/file_name"}},"file_size":{"type":"integer","term":{"$ref":"_terms.yaml#/file_size"}},"file_format":{"type":"string","term":{"$ref":"_terms.yaml#/file_format"}},"md5sum":{"type":"string","term":{"$ref":"_terms.yaml#/md5sum"}},"object_id":{"type":"string","description":"The GUID of the object in the index service."},"release_state":{"description":"Release state of an entity.","default":"unreleased","enum":["unreleased","released","redacted"]},"data_bundle_state":{"description":"State of a data bundle.","default":"submitted","enum":["submitted","validated","error","released","suppressed","redacted"]},"data_file_error_type":{"term":{"$ref":"_terms.yaml#/data_file_error_type"},"enum":["file_size","file_format","md5sum"]},"state":{"term":{"$ref":"_terms.yaml#/state"},"default":"validated","downloadable":["uploaded","md5summed","validating","validated","error","invalid","released"],"public":["live"],"oneOf":[{"enum":["uploading","uploaded","md5summing","md5summed","validating","error","invalid","suppressed","redacted","live"]},{"enum":["validated","submitted","released"]}]},"file_state":{"term":{"$ref":"_terms.yaml#/file_state"},"default":"registered","enum":["registered","uploading","uploaded","validating","validated","submitted","processing","processed","released","error"]},"qc_metrics_state":{"term":{"$ref":"_terms.yaml#/qc_metric_state"},"enum":["FAIL","PASS","WARN"]},"project_id":{"type":"string","term":{"$ref":"_terms.yaml#/project_id"}},"data_file_properties":{"$ref":"#/ubiquitous_properties","file_name":{"$ref":"#/file_name"},"file_size":{"$ref":"#/file_size"},"md5sum":{"$ref":"#/md5sum"},"file_state":{"$ref":"#/file_state"},"error_type":{"$ref":"#/data_file_error_type"},"object_id":{"$ref":"#/object_id"},"state":{"$ref":"#/state"}},"workflow_properties":{"$ref":"#/ubiquitous_properties","workflow_description":{"description":"A brief description of the workflow or pipeline used to generate the data.","type":"string"},"workflow_name":{"description":"The name of an encapsulated bioinformatics workflow or pipeline.","type":"string"},"workflow_link":{"description":"Link to Github hash for the CWL workflow used.","type":"string"},"workflow_version":{"description":"Major version for a GDC workflow.","type":"string"},"workflow_start_datetime":{"$ref":"#/datetime"},"workflow_end_datetime":{"$ref":"#/datetime"}},"ubiquitous_properties":{"type":{"type":"string"},"id":{"$ref":"#/UUID","systemAlias":"node_id"},"submitter_id":{"type":["string"],"description":"A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.\n"},"state":{"$ref":"#/state"},"project_id":{"$ref":"#/project_id"},"created_datetime":{"$ref":"#/datetime"},"updated_datetime":{"$ref":"#/datetime"}}},"_settings.yaml":{"enable_case_cache":false,"_dict_commit":"c42877be4bed838950ac92f4bfceb2e3f5ced5c0","_dict_version":"0.8.6-9-gc42877b"},"program.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"program","title":"Program","type":"object","category":"administrative","program":"*","project":"*","description":"A broad framework of goals to be achieved. (NCIt C52647)\n","additionalProperties":false,"submittable":false,"validators":null,"systemProperties":["id"],"required":["name","dbgap_accession_number"],"uniqueKeys":[["id"],["name"]],"links":[],"properties":{"type":{"type":"string"},"id":{"$ref":"_definitions.yaml#/UUID","systemAlias":"node_id"},"name":{"type":"string","description":"Full name/title of the program."},"dbgap_accession_number":{"type":"string","description":"The dbgap accession number provided for the program."}}},"analyte.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"analyte","title":"Analyte","type":"object","namespace":"https://data.bloodpac.org","category":"biospecimen","program":"*","project":"*","description":"Any aspect of an aliquot used in an analysis or assay to characterize the sample. These aspects range from molecules, such as DNA and RNA, that can be extracted from the aliquot to general descriptions of the aliquot's components, such as cell count and morphology.\n","additionalProperties":false,"submittable":true,"validators":null,"systemProperties":["id","project_id","state","created_datetime","updated_datetime"],"required":["submitter_id","type","analyte_type","analyte_isolation_method"],"links":[{"exclusive":false,"required":true,"subgroup":[{"name":"aliquots","backref":"analytes","label":"derived_from","target_type":"aliquot","multiplicity":"many_to_many","required":false},{"name":"studies","backref":"analytes","label":"analyzed_for","target_type":"study","multiplicity":"many_to_many","required":false}]}],"uniqueKeys":[["id"],["project_id","submitter_id"]],"properties":{"$ref":"_definitions.yaml#/ubiquitous_properties","analyte_isolation_method":{"description":"The name or general description of the method used to isolate the analyte. Alternatively, if you have provided a protocol, put the file_name here.\n","type":"string"},"analyte_type":{"term":{"$ref":"_terms.yaml#/analyte_type"},"enum":["DNA","RNA","Peptide","Protein","Morphology","Cell Count"]},"cell_type":{"description":"In the case of single cell analysis, this is the type of cell being analyzed.\n","enum":["All CTC Populations","Apoptotic CTC","Biomarker Positive All CTC Populations","Biomarker Positive Traditional CTC","Cytokeratin Negative CTC","Cytokeratin Negative CTC Cluster","Cytokeratin Positive CTC","Cytokeratin Positive CTC Cluster","Nucleated Cell","Small CTC","Small CTC Cluster","Traditional CTC","Traditional CTC Cluster","White Blood Cell"]},"cell_identifier":{"description":"The identifying name or number for the cell being identified.\n","type":"string"},"days_to_assay":{"description":"The amount of time, in days, between the date used for index and the assay used to address this analyte.\n","type":"integer"},"frame_identifier":{"description":"In an analysis of a slide, the frame denotes the region of the slide that is being examined. Within a frame are multiple cells.\n","type":"string"},"llod":{"description":"The lower limit of detection. The lowest quantity of a substance that can be distinguished from the absence of that substance (a blank value) within a stated confidence limit (generally 1%). If the lower limit of detection is not a number ('WT', for example), see 'llod_other'.","type":"number"},"run_identifier":{"description":"The identifier given to the run during which this particular analyte was tested or evaluated. If you analyze multiple analytes through the same experimentation run, this is a good way to keep track.\n","type":"string"},"specificity":{"description":"The true negative rate. If this value is not a number ('WT', for example), see 'specificty_other'.","type":"number"},"sensitivity":{"description":"The true positive rate. If this value is not a number ('WT', for example), see 'sensitivity_other'.","type":"number"},"specificity_other":{"description":"If the true negative rate is something other than a number (for example, 'WT'), enter the text here.","type":"string"},"sensitivity_other":{"description":"If the true positive rate is not a numnber (for example, 'WT'), enter the text here.","type":"string"},"llod_other":{"description":"If the lower limit of detection is not a number (for example, 'WT'), enter the text here.","type":"string"},"aliquots":{"$ref":"_definitions.yaml#/to_many"},"studies":{"$ref":"_definitions.yaml#/to_many"}}},"aliquot.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"aliquot","title":"Aliquot","type":"object","category":"biospecimen","namespace":"https://data.bloodpac.org","program":"*","project":"*","description":"Pertaining to a portion of the whole; any one of two or more samples of something, of the same volume or weight.\n","additionalProperties":false,"submittable":true,"validators":[],"systemProperties":["id","project_id","state","created_datetime","updated_datetime"],"required":["submitter_id","type","aliquot_container","clinical_or_contrived","preservation_method","storage_temperature"],"uniqueKeys":[["id"],["project_id","submitter_id"]],"links":[{"exclusive":false,"required":true,"subgroup":[{"name":"samples","backref":"aliquots","label":"derived_from","multiplicity":"many_to_many","target_type":"sample","required":false},{"name":"studies","backref":"aliquots","label":"analyzed_for","target_type":"study","multiplicity":"many_to_many","required":false}]}],"constraints":null,"properties":{"$ref":"_definitions.yaml#/ubiquitous_properties","aliquot_container":{"description":"The device in which the final aliquot is held. Slides or vials.","enum":["Serum Card","Slide","Vial"]},"aliquot_quantity":{"description":"The quantity in micrograms (ug) of the aliquot derived from the sample and used for experimentation.","type":"number"},"aliquot_volume":{"description":"The volume in microliters (uL) of the aliquot derived from the sample and used for experimentation.","type":"number"},"clinical_or_contrived":{"description":"Is the aliquot clinical or contrived?","enum":["Clinical","Contrived"]},"contrivance_method":{"description":"The name or general description of the contrivance(s) added to the biological aliquot. Alternatively, if you have provided a contrivance protocol, enter its file_name here.\n","type":"string"},"hours_to_freezer_lower":{"description":"The lower limit on the amount of time, in hours, that it took between the sample being fractionated and the aliquot being frozen or otherwise preserved. If the exact time is known, make this value equal to that of the upper limit. If the time is completely unknown or if no fractionation was performed on this sample, enter the appropriate value in hours_to_freezer_lower_other.\n","type":"number"},"hours_to_freezer_upper":{"description":"The upper limit on the amount of time, in hours, that it took between the sample being fractionated and the aliquot being frozen or otherwise preserved. If the exact time is known, make this value equal to that of the lower limit. If the time is completely unknown or if no fractionation was performed on this sample, enter the appropriate value in hours_to_freezer_upper_other.\n","type":"number"},"hours_to_freezer_lower_other":{"description":"If the lower limit on the amount of time, in hours, that it took between the sample being fractionated and the aliquot being frozen or otherwise preserved is completely unknown or if no fractionation was performed on this sample, enter the appropriate value here.\n","enum":["Not Applicable","Unknown"]},"hours_to_freezer_upper_other":{"description":"If the upper limit on the amount of time, in hours, that it took between the sample being fractionated and the aliquot being frozen or otherwise preserved is completely unknown or if no fractionation was performed on this sample, enter the appropriate value here.\n","enum":["Not Applicable","Unknown"]},"methanol_added":{"description":"In the preparation of a slide, was methanol added as a fixative? True/False.","type":"boolean"},"preservation_method":{"term":{"$ref":"_terms.yaml#/preservation_method"},"enum":["Cryopreserved","FFPE","Fresh","OCT","Snap Frozen","Frozen","Unknown"]},"storage_temperature":{"description":"The temperature, in centrigrade, at which the aliquot was preserved and/or stored.","type":"number"},"samples":{"$ref":"_definitions.yaml#/to_many"},"studies":{"$ref":"_definitions.yaml#/to_many"}}},"core_metadata_collection.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"core_metadata_collection","title":"Core Metadata Collection","type":"object","namespace":"https://data.bloodpac.org","category":"administrative","program":"*","project":"*","description":"Structured description of a collection of several datasets\n","additionalProperties":false,"submittable":true,"validators":null,"systemProperties":["id","project_id","state","created_datetime","updated_datetime"],"links":[{"name":"projects","backref":"core_metadata_collections","label":"data_from","target_type":"project","multiplicity":"many_to_one","required":true}],"uniqueKeys":[["id"],["project_id","submitter_id"]],"required":["submitter_id","type","projects"],"properties":{"$ref":"_definitions.yaml#/ubiquitous_properties","contributor":{"description":"An entity responsible for making contributions to the resource. Examples of a Contributor include a person, an organization, or a service. Typically, the name of a Contributor should be used to indicate the entity.\n","type":"string"},"coverage":{"description":"The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant. Spatial topic and spatial applicability may be a named place or a location specified by its geographic coordinates. Temporal topic may be a named period, date, or date range. A jurisdiction may be a named administrative entity or a geographic place to which the resource applies. Recommended best practice is to use a controlled vocabulary such as the Thesaurus of Geographic Names [TGN] (http://www.getty.edu/research/tools/vocabulary/tgn/index.html). Where appropriate, named places or time periods can be used in preference to numeric identifiers such as sets of coordinates or date ranges.\n","type":"string"},"creator":{"description":"An entity primarily responsible for making the resource. Examples of a Creator include a person, an organization, or a service. Typically, the name of a Creator should be used to indicate the entity.\n","type":"string"},"date":{"$ref":"_definitions.yaml#/datetime"},"description":{"description":"An account of the resource. Description may include but is not limited to: an abstract, a table of contents, a graphical representation, or a free-text account of the resource.\n","type":"string"},"format":{"description":"The file format, physical medium, or dimensions of the resource. Examples of dimensions include size and duration. Recommended best practice is to use a controlled vocabulary such as the list of Internet Media Types [MIME] (http://www.iana.org/assignments/media-types/).\n","type":"string"},"language":{"description":"A language of the resource. Recommended best practice is to use a controlled vocabulary such as RFC 4646 (http://www.ietf.org/rfc/rfc4646.txt).\n","type":"string"},"publisher":{"description":"An entity responsible for making the resource available. Examples of a Publisher include a person, an organization, or a service. Typically, the name of a Publisher should be used to indicate the entity.\n","type":"string"},"relation":{"description":"A related resource. Recommended best practice is to identify the related resource by means of a string conforming to a formal identification system. \n","type":"string"},"rights":{"description":"Information about rights held in and over the resource. Typically, rights information includes a statement about various property rights associated with the resource, including intellectual property rights.\n","type":"string"},"source":{"description":"A related resource from which the described resource is derived. The described resource may be derived from the related resource in whole or in part. Recommended best practice is to identify the related resource by means of a string conforming to a formal identification system.\n","type":"string"},"subject":{"description":"The topic of the resource. Typically, the subject will be represented using keywords, key phrases, or classification codes. Recommended best practice is to use a controlled vocabulary.\n","type":"string"},"title":{"description":"A name given to the resource. Typically, a Title will be a name by which the resource is formally known.\n","type":"string"},"data_type":{"description":"The nature or genre of the resource. Recommended best practice is to use a controlled vocabulary such as the DCMI Type Vocabulary [DCMITYPE]. To describe the file format, physical medium, or dimensions of the resource, use the Format element.\n","type":"string"},"projects":{"$ref":"_definitions.yaml#/to_one_project"}}},"aligned_reads_index.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"aligned_reads_index","title":"Aligned Reads Index","type":"object","namespace":"https://data.bloodpac.org","category":"index_file","program":"*","project":"*","description":"Data file containing the index for a set of aligned reads.","additionalProperties":false,"submittable":true,"validators":null,"systemProperties":["id","project_id","created_datetime","updated_datetime","state","file_state","error_type"],"links":[{"exclusive":false,"required":true,"subgroup":[{"name":"core_metadata_collections","backref":"aligned_reads_indexes","label":"data_from","target_type":"core_metadata_collection","multiplicity":"many_to_one","required":false},{"name":"submitted_aligned_reads_files","backref":"aligned_reads_indexes","label":"derived_from","target_type":"submitted_aligned_reads","multiplicity":"one_to_one","required":false}]}],"required":["submitter_id","type","file_name","file_size","md5sum","data_category","data_type","data_format"],"uniqueKeys":[["id"],["project_id","submitter_id"]],"properties":{"$ref":"_definitions.yaml#/data_file_properties","data_category":{"term":{"$ref":"_terms.yaml#/data_category"},"enum":["Sequencing Reads"]},"data_type":{"term":{"$ref":"_terms.yaml#/data_type"},"enum":["Aligned Reads Index"]},"data_format":{"term":{"$ref":"_terms.yaml#/data_format"},"enum":["BAI"]},"submitted_aligned_reads_files":{"$ref":"_definitions.yaml#/to_one"},"core_metadata_collections":{"$ref":"_definitions.yaml#/to_many"}}},"project.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"project","title":"Project","type":"object","program":"*","project":"*","category":"administrative","description":"Any specifically defined piece of work that is undertaken or attempted to meet a single requirement. (NCIt C47885)\n","additionalProperties":false,"submittable":true,"validators":null,"systemProperties":["id","state","released","releasable","intended_release_date"],"required":["code","name","programs","dbgap_accession_number"],"uniqueKeys":[["id"],["code"]],"links":[{"name":"programs","backref":"projects","label":"member_of","target_type":"program","multiplicity":"many_to_one","required":true}],"constraints":null,"properties":{"type":{"type":"string"},"id":{"$ref":"_definitions.yaml#/UUID","systemAlias":"node_id","description":"UUID for the project."},"name":{"type":"string","description":"Display name/brief description for the project."},"code":{"type":"string","description":"Unique identifier for the project."},"investigator_name":{"description":"Name of the principal investigator for the project.","type":"string"},"investigator_affiliation":{"description":"The investigator's affiliation with respect to a research institution.","type":"string"},"date_collected":{"description":"The date or date range in which the project data was collected.","type":"string"},"availability_type":{"description":"Is the project open or restricted?","enum":["Open","Restricted"]},"availability_mechanism":{"description":"Mechanism by which the project will be made avilable.","type":"string"},"support_source":{"description":"The name of source providing support/grant resources.","type":"string"},"support_id":{"description":"The ID of the source providing support/grant resources.","type":"string"},"programs":{"$ref":"_definitions.yaml#/to_one","description":"Indicates that the project is logically part of the indicated project.\n"},"state":{"description":"The possible states a project can be in.  All but `open` are\nequivalent to some type of locked state.\n","default":"open","enum":["open","review","submitted","processing","closed","legacy"]},"released":{"description":"To release a project is to tell the GDC to include all submitted\nentities in the next GDC index.\n","default":false,"type":"boolean"},"releasable":{"description":"A project can only be released by the user when `releasable` is true.\n","default":false,"type":"boolean"},"intended_release_date":{"description":"Tracks a Project's intended release date.","type":"string","format":"date-time"},"dbgap_accession_number":{"type":"string","description":"The dbgap accession number provided for the project."}}},"followup.yaml":{"schema":"http://json-schema.org/draft-04/schema#","id":"followup","title":"Follow-Up","type":"object","namespace":"https://data.bloodpac.org","category":"clinical","program":"*","project":"*","description":"A visit by a patient or study participant to a medical professional. A clinical encounter that encompasses planned and unplanned trial interventions, procedures and assessments that may be performed on a subject. A visit has a start and an end, each described with a rule. The process by which information about the health status of an individual is obtained before and after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done.\n","additionalProperties":false,"submittable":true,"validators":null,"systemProperties":["id","project_id","state","created_datetime","updated_datetime"],"links":[{"name":"cases","backref":"followups","label":"describes","target_type":"case","multiplicity":"many_to_one","required":true}],"required":["submitter_id","type","days_to_followup","cases"],"uniqueKeys":[["id"],["project_id","submitter_id"]],"properties":{"$ref":"_definitions.yaml#/ubiquitous_properties","adverse_event":{"description":"Text that represents the Common Terminology Criteria for Adverse Events low level term name for an adverse event.","enum":["Abdominal distension","Abdominal infection","Abdominal pain","Abdominal soft tissue necrosis","Abducens nerve disorder","Accessory nerve disorder","Acidosis","Acoustic nerve disorder NOS","Activated partial thromboplastin time prolonged","Acute coronary syndrome","Acute kidney injury","Adrenal insufficiency","Adult respiratory distress syndrome","Agitation","Akathisia","Alanine aminotransferase increased","Alcohol intolerance","Alkaline phosphatase increased","Alkalosis","Allergic reaction","Allergic rhinitis","Alopecia","Amnesia","Anal fistula","Anal hemorrhage","Anal mucositis","Anal necrosis","Anal pain","Anal stenosis","Anal ulcer","Anaphylaxis","Anemia","Ankle fracture","Anorectal infection","Anorexia","Anorgasmia","Anxiety","Aortic injury","Aortic valve disease","Aphonia","Apnea","Appendicitis","Appendicitis perforated","Arachnoiditis","Arterial injury","Arteritis infective","Arthralgia","Arthritis","Ascites","Aspartate aminotransferase increased","Aspiration","Asystole","Ataxia","Atelectasis","Atrial fibrillation","Atrial flutter","Atrioventricular block complete","Atrioventricular block first degree","Autoimmune disorder","Avascular necrosis","Azoospermia","Back pain","Bile duct stenosis","Biliary anastomotic leak","Biliary fistula","Biliary tract infection","Bladder anastomotic leak","Bladder infection","Bladder perforation","Bladder spasm","Bloating","Blood and lymphatic system disorders","Blood antidiuretic hormone abnormal","Blood bilirubin increased","Blood corticotrophin decreased","Blood gonadotrophin abnormal","Blood prolactin abnormal","Blurred vision","Body odor","Bone infection","Bone marrow hypocellular","Bone pain","Brachial plexopathy","Breast atrophy","Breast infection","Breast pain","Bronchial fistula","Bronchial infection","Bronchial obstruction","Bronchial stricture","Bronchopleural fistula","Bronchopulmonary hemorrhage","Bronchospasm","Bruising","Bullous dermatitis","Burn","Buttock pain","Capillary leak syndrome","Carbon monoxide diffusing capacity decreased","Cardiac arrest","Cardiac disorders","Cardiac troponin I increased","Cardiac troponin T increased","Cataract","Catheter related infection","CD4 lymphocytes decreased","Cecal hemorrhage","Cecal infection","Central nervous system necrosis","Cerebrospinal fluid leakage","Cervicitis infection","Cheilitis","Chest pain - cardiac","Chest wall pain","Chills","Cholecystitis","Cholesterol high","Chronic kidney disease","Chylothorax","Cognitive disturbance","Colitis","Colonic fistula","Colonic hemorrhage","Colonic obstruction","Colonic perforation","Colonic stenosis","Colonic ulcer","Concentration impairment","Conduction disorder","Confusion","Congenital, familial and genetic disorders","Conjunctivitis","Conjunctivitis infective","Constipation","Constrictive pericarditis","Corneal infection","Corneal ulcer","Cough","CPK increased","Cranial nerve infection","Creatinine increased","Cushingoid","Cystitis noninfective","Cytokine release syndrome","Death neonatal","Death NOS","Dehydration","Delayed orgasm","Delayed puberty","Delirium","Delusions","Dental caries","Depressed level of consciousness","Depression","Dermatitis radiation","Device related infection","Diarrhea","Disseminated intravascular coagulation","Dizziness","Dry eye","Dry mouth","Dry skin","Duodenal fistula","Duodenal hemorrhage","Duodenal infection","Duodenal obstruction","Duodenal perforation","Duodenal stenosis","Duodenal ulcer","Dysarthria","Dysesthesia","Dysgeusia","Dysmenorrhea","Dyspareunia","Dyspepsia","Dysphagia","Dysphasia","Dyspnea","Ear and labyrinth disorders","Ear pain","Edema cerebral","Edema face","Edema limbs","Edema trunk","Ejaculation disorder","Ejection fraction decreased","Electrocardiogram QT corrected interval prolonged","Encephalitis infection","Encephalomyelitis infection","Encephalopathy","Endocarditis infective","Endocrine disorders","Endophthalmitis","Enterocolitis","Enterocolitis infectious","Enterovesical fistula","Epistaxis","Erectile dysfunction","Erythema multiforme","Erythroderma","Esophageal anastomotic leak","Esophageal fistula","Esophageal hemorrhage","Esophageal infection","Esophageal necrosis","Esophageal obstruction","Esophageal pain","Esophageal perforation","Esophageal stenosis","Esophageal ulcer","Esophageal varices hemorrhage","Esophagitis","Euphoria","Exostosis","External ear inflammation","External ear pain","Extraocular muscle paresis","Extrapyramidal disorder","Eye disorders","Eye infection","Eye pain","Eyelid function disorder","Facial muscle weakness","Facial nerve disorder","Facial pain","Fall","Fallopian tube anastomotic leak","Fallopian tube obstruction","Fallopian tube perforation","Fallopian tube stenosis","Fat atrophy","Fatigue","Febrile neutropenia","Fecal incontinence","Female genital tract fistula","Feminization acquired","Fetal death","Fetal growth retardation","Fever","Fibrinogen decreased","Fibrosis deep connective tissue","Flank pain","Flashing lights","Flatulence","Floaters","Flu like symptoms","Flushing","Forced expiratory volume decreased","Fracture","Gait disturbance","Gallbladder fistula","Gallbladder infection","Gallbladder necrosis","Gallbladder obstruction","Gallbladder pain","Gallbladder perforation","Gastric anastomotic leak","Gastric fistula","Gastric hemorrhage","Gastric necrosis","Gastric perforation","Gastric stenosis","Gastric ulcer","Gastritis","Gastroesophageal reflux disease","Gastrointestinal anastomotic leak","Gastrointestinal disorders","Gastrointestinal fistula","Gastrointestinal pain","Gastrointestinal stoma necrosis","Gastroparesis","General disorders and administration site conditions","Generalized muscle weakness","Genital edema","GGT increased","Gingival pain","Glaucoma","Glossopharyngeal nerve disorder","Glucose intolerance","Growth accelerated","Growth hormone abnormal","Growth suppression","Gum infection","Gynecomastia","Hallucinations","Haptoglobin decreased","Head soft tissue necrosis","Headache","Hearing impaired","Heart failure","Hematoma","Hematosalpinx","Hematuria","Hemoglobin increased","Hemoglobinuria","Hemolysis","Hemolytic uremic syndrome","Hemorrhoidal hemorrhage","Hemorrhoids","Hepatic failure","Hepatic hemorrhage","Hepatic infection","Hepatic necrosis","Hepatic pain","Hepatitis viral","Hepatobiliary disorders","Hiccups","Hip fracture","Hirsutism","Hoarseness","Hot flashes","Hydrocephalus","Hypercalcemia","Hyperglycemia","Hyperhidrosis","Hyperkalemia","Hypermagnesemia","Hypernatremia","Hyperparathyroidism","Hypersomnia","Hypertension","Hyperthyroidism","Hypertrichosis","Hypertriglyceridemia","Hyperuricemia","Hypoalbuminemia","Hypocalcemia","Hypoglossal nerve disorder","Hypoglycemia","Hypohidrosis","Hypokalemia","Hypomagnesemia","Hyponatremia","Hypoparathyroidism","Hypophosphatemia","Hypotension","Hypothermia","Hypothyroidism","Hypoxia","Ileal fistula","Ileal hemorrhage","Ileal obstruction","Ileal perforation","Ileal stenosis","Ileal ulcer","Ileus","Immune system disorders","Infections and infestations","Infective myositis","Infusion related reaction","Infusion site extravasation","Injection site reaction","Injury to carotid artery","Injury to inferior vena cava","Injury to jugular vein","Injury to superior vena cava","Injury, poisoning and procedural complications","INR increased","Insomnia","Intestinal stoma leak","Intestinal stoma obstruction","Intestinal stoma site bleeding","Intra-abdominal hemorrhage","Intracranial hemorrhage","Intraoperative arterial injury","Intraoperative breast injury","Intraoperative cardiac injury","Intraoperative ear injury","Intraoperative endocrine injury","Intraoperative gastrointestinal injury","Intraoperative head and neck injury","Intraoperative hemorrhage","Intraoperative hepatobiliary injury","Intraoperative musculoskeletal injury","Intraoperative neurological injury","Intraoperative ocular injury","Intraoperative renal injury","Intraoperative reproductive tract injury","Intraoperative respiratory injury","Intraoperative skin injury","Intraoperative splenic injury","Intraoperative urinary injury","Intraoperative venous injury","Investigations","Iron overload","Irregular menstruation","Irritability","Ischemia cerebrovascular","IVth nerve disorder","Jejunal fistula","Jejunal hemorrhage","Jejunal obstruction","Jejunal perforation","Jejunal stenosis","Jejunal ulcer","Joint effusion","Joint infection","Joint range of motion decreased","Joint range of motion decreased cervical spine","Joint range of motion decreased lumbar spine","Keratitis","Kidney anastomotic leak","Kidney infection","Kyphosis","Lactation disorder","Large intestinal anastomotic leak","Laryngeal edema","Laryngeal fistula","Laryngeal hemorrhage","Laryngeal inflammation","Laryngeal mucositis","Laryngeal obstruction","Laryngeal stenosis","Laryngitis","Laryngopharyngeal dysesthesia","Laryngospasm","Left ventricular systolic dysfunction","Lethargy","Leukemia secondary to oncology chemotherapy","Leukocytosis","Leukoencephalopathy","Libido decreased","Libido increased","Lip infection","Lip pain","Lipase increased","Lipohypertrophy","Localized edema","Lordosis","Lower gastrointestinal hemorrhage","Lung infection","Lymph gland infection","Lymph leakage","Lymph node pain","Lymphedema","Lymphocele","Lymphocyte count decreased","Lymphocyte count increased","Malabsorption","Malaise","Mania","Mediastinal hemorrhage","Mediastinal infection","Memory impairment","Meningismus","Meningitis","Menopause","Menorrhagia","Metabolism and nutrition disorders","Middle ear inflammation","Mitral valve disease","Mobitz (type) II atrioventricular block","Mobitz type I","Movements involuntary","Mucosal infection","Mucositis oral","Multi-organ failure","Muscle weakness left-sided","Muscle weakness lower limb","Muscle weakness right-sided","Muscle weakness trunk","Muscle weakness upper limb","Musculoskeletal and connective tissue disorders","Musculoskeletal deformity","Myalgia","Myelitis","Myelodysplastic syndrome","Myocardial infarction","Myocarditis","Myositis","Nail discoloration","Nail infection","Nail loss","Nail ridging","Nasal congestion","Nausea","Neck edema","Neck pain","Neck soft tissue necrosis","Neoplasms benign, malignant and unspecified (incl cysts and polyps)","Nervous system disorders","Neuralgia","Neutrophil count decreased","Night blindness","Nipple deformity","Non-cardiac chest pain","Nystagmus","Obesity","Obstruction gastric","Oculomotor nerve disorder","Olfactory nerve disorder","Oligospermia","Optic nerve disorder","Oral cavity fistula","Oral dysesthesia","Oral hemorrhage","Oral pain","Osteonecrosis of jaw","Osteoporosis","Otitis externa","Otitis media","Ovarian hemorrhage","Ovarian infection","Ovarian rupture","Ovulation pain","Pain","Pain in extremity","Pain of skin","Palmar-plantar erythrodysesthesia syndrome","Palpitations","Pancreas infection","Pancreatic anastomotic leak","Pancreatic duct stenosis","Pancreatic enzymes decreased","Pancreatic fistula","Pancreatic hemorrhage","Pancreatic necrosis","Pancreatitis","Papilledema","Papulopustular rash","Paresthesia","Paronychia","Paroxysmal atrial tachycardia","Pelvic floor muscle weakness","Pelvic infection","Pelvic pain","Pelvic soft tissue necrosis","Penile infection","Penile pain","Perforation bile duct","Pericardial effusion","Pericardial tamponade","Pericarditis","Perineal pain","Periodontal disease","Periorbital edema","Periorbital infection","Peripheral ischemia","Peripheral motor neuropathy","Peripheral nerve infection","Peripheral sensory neuropathy","Peritoneal infection","Peritoneal necrosis","Personality change","Phantom pain","Pharyngeal anastomotic leak","Pharyngeal fistula","Pharyngeal hemorrhage","Pharyngeal mucositis","Pharyngeal necrosis","Pharyngeal stenosis","Pharyngitis","Pharyngolaryngeal pain","Phlebitis","Phlebitis infective","Photophobia","Photosensitivity","Platelet count decreased","Pleural effusion","Pleural hemorrhage","Pleural infection","Pleuritic pain","Pneumonitis","Pneumothorax","Portal hypertension","Portal vein thrombosis","Postnasal drip","Postoperative hemorrhage","Postoperative thoracic procedure complication","Precocious puberty","Pregnancy, puerperium and perinatal conditions","Premature delivery","Premature menopause","Presyncope","Proctitis","Productive cough","Prolapse of intestinal stoma","Prolapse of urostomy","Prostate infection","Prostatic hemorrhage","Prostatic obstruction","Prostatic pain","Proteinuria","Pruritus","Psychiatric disorders","Psychosis","Pulmonary edema","Pulmonary fibrosis","Pulmonary fistula","Pulmonary hypertension","Pulmonary valve disease","Purpura","Pyramidal tract syndrome","Radiation recall reaction (dermatologic)","Radiculitis","Rash acneiform","Rash maculo-papular","Rash pustular","Rectal anastomotic leak","Rectal fistula","Rectal hemorrhage","Rectal mucositis","Rectal necrosis","Rectal obstruction","Rectal pain","Rectal perforation","Rectal stenosis","Rectal ulcer","Recurrent laryngeal nerve palsy","Renal and urinary disorders","Renal calculi","Renal colic","Renal hemorrhage","Reproductive system and breast disorders","Respiratory failure","Respiratory, thoracic and mediastinal disorders","Restlessness","Restrictive cardiomyopathy","Retinal detachment","Retinal tear","Retinal vascular disorder","Retinoic acid syndrome","Retinopathy","Retroperitoneal hemorrhage","Reversible posterior leukoencephalopathy syndrome","Rhinitis infective","Right ventricular dysfunction","Salivary duct inflammation","Salivary gland fistula","Salivary gland infection","Scalp pain","Scleral disorder","Scoliosis","Scrotal infection","Scrotal pain","Seizure","Sepsis","Seroma","Serum amylase increased","Serum sickness","Sick sinus syndrome","Sinus bradycardia","Sinus disorder","Sinus pain","Sinus tachycardia","Sinusitis","Skin and subcutaneous tissue disorders","Skin atrophy","Skin hyperpigmentation","Skin hypopigmentation","Skin induration","Skin infection","Skin ulceration","Sleep apnea","Small intestinal anastomotic leak","Small intestinal mucositis","Small intestinal obstruction","Small intestinal perforation","Small intestinal stenosis","Small intestine infection","Small intestine ulcer","Sneezing","Social circumstances","Soft tissue infection","Soft tissue necrosis lower limb","Soft tissue necrosis upper limb","Somnolence","Sore throat","Spasticity","Spermatic cord anastomotic leak","Spermatic cord hemorrhage","Spermatic cord obstruction","Spinal fracture","Spleen disorder","Splenic infection","Stenosis of gastrointestinal stoma","Stevens-Johnson syndrome","Stoma site infection","Stomach pain","Stomal ulcer","Stridor","Stroke","Sudden death NOS","Suicidal ideation","Suicide attempt","Superficial soft tissue fibrosis","Superficial thrombophlebitis","Superior vena cava syndrome","Supraventricular tachycardia","Surgical and medical procedures","Syncope","Telangiectasia","Testicular disorder","Testicular hemorrhage","Testicular pain","Thromboembolic event","Thrombotic thrombocytopenic purpura","Tinnitus","Tooth development disorder","Tooth discoloration","Tooth infection","Toothache","Toxic epidermal necrolysis","Tracheal fistula","Tracheal hemorrhage","Tracheal mucositis","Tracheal obstruction","Tracheal stenosis","Tracheitis","Tracheostomy site bleeding","Transient ischemic attacks","Treatment related secondary malignancy","Tremor","Tricuspid valve disease","Trigeminal nerve disorder","Trismus","Tumor lysis syndrome","Tumor pain","Typhlitis","Unequal limb length","Unintended pregnancy","Upper gastrointestinal hemorrhage","Upper respiratory infection","Ureteric anastomotic leak","Urethral anastomotic leak","Urethral infection","Urinary fistula","Urinary frequency","Urinary incontinence","Urinary retention","Urinary tract infection","Urinary tract obstruction","Urinary tract pain","Urinary urgency","Urine discoloration","Urine output decreased","Urostomy leak","Urostomy obstruction","Urostomy site bleeding","Urostomy stenosis","Urticaria","Uterine anastomotic leak","Uterine fistula","Uterine hemorrhage","Uterine infection","Uterine obstruction","Uterine pain","Uterine perforation","Uveitis","Vaginal anastomotic leak","Vaginal discharge","Vaginal dryness","Vaginal fistula","Vaginal hemorrhage","Vaginal infection","Vaginal inflammation","Vaginal obstruction","Vaginal pain","Vaginal perforation","Vaginal stricture","Vaginismus","Vagus nerve disorder","Vas deferens anastomotic leak","Vascular access complication","Vascular disorders","Vasculitis","Vasovagal reaction","Venous injury","Ventricular arrhythmia","Ventricular fibrillation","Ventricular tachycardia","Vertigo","Vestibular disorder","Virilization","Visceral arterial ischemia","Vital capacity abnormal","Vitreous hemorrhage","Voice alteration","Vomiting","Vulval infection","Watering eyes","Weight gain","Weight loss","Wheezing","White blood cell decreased","Wolff-Parkinson-White syndrome","Wound complication","Wound dehiscence","Wound infection","Wrist fracture"]},"bmi":{"description":"The body mass divided by the square of the body height expressed in units of kg/m^2.","type":"number"},"cause_of_response":{"description":"A specific regimen or line of therapy responsible for the patient's observed improvement achived at a certain point in time during a patient's treatment protocol.\n","type":"string"},"days_to_adverse_event":{"description":"Number of days between the date used for index and the date the patient had an adverse event.","type":"integer"},"days_to_followup":{"description":"Number of days between the date used for index and the date the patient was seen or contacted at follow-up.","type":"integer"},"days_to_progression":{"description":"Number of days between the date used for index and the date the patient was diagnosed with progression of disease.","type":"integer"},"days_to_recurrence":{"description":"Number of days between the date used for index and the date the patient was diagnosed with a recurrent malignancy.","type":"integer"},"disease_response":{"description":"The observed improvement achieved at a certain point in time during a patient's treatment protocol.","enum":["AJ-Adjuvant Therapy","CPD-Clinical Progression","CR-Complete Response","CRU-Complete Response Unconfirmed","DU-Disease Unchanged","IMR-Immunoresponse","IPD-Immunoprogression","MR-Minimal/Marginal response","MX-Mixed response","Non-CR/Non-PD-Non-CR/Non-PD","NPB-No Palliative Benefit","NR-NO RESPONSE","PA-Palliative Therapy","PB-Palliative Benefit","PD-Progressive Disease","PPD-Pseudoprogression","PR-Partial Response","PSR-Pseudoresponse","RD-Responsive Disease","RP-Response","RPD-Radiographic Progressive Disease","sCR-Stringent Complete Response","SD-Stable Disease","SPD-Surgical progression","TE-Too early","VGPR-Very Good Partial Response"]},"ecog_performance_status":{"description":"The ECOG functional performance status of the patient/participant.","enum":["0","1","2","3","4","5"]},"height":{"description":"The height of the patient in centimeters.","type":"number"},"progression_or_recurrence":{"description":"Indicator to identify whether a patient has had a recurrent or relapsed malignancy or a progression of disease.","enum":["Yes","No","Unknown"]},"time_from_alcohol":{"description":"Hours since the patient last consumed alcohol.\n","type":"number"},"time_from_exercise":{"description":"Hours since the patient last exercised.\n","type":"number"},"time_from_food":{"description":"Hours since the patient last consumed food.\n","type":"number"},"time_from_physical_trauma":{"description":"Hours since the patient last experienced physical trauma.\n","type":"number"},"time_from_biopsy":{"description":"Hours since the patient last underwent a biopsy; please record the biopsy information in the 'diagnostic_test' node and link that record to this followup record.\n","type":"number"},"time_from_recreational_drugs":{"description":"Hours since the patient last used recreational drugs.\n","type":"number"},"time_from_tobacco":{"description":"Hours since the patient last used tobacco.\n","type":"number"},"time_from_treatment":{"description":"Hours since the patient received a treatment, including surgical procedures or medications; please record the treatment information in the 'treatment' node and link that record to this followup record.\n","type":"number"},"weight":{"description":"The weight of the patient measured in kilograms.","type":"number"},"cases":{"$ref":"_definitions.yaml#/to_one"}}},"case.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"case","title":"Case","type":"object","namespace":"https://data.bloodpac.org","category":"administrative","program":"*","project":"*","description":"The collection of all data related to a specific subject in the context of a specific experiment.\n","additionalProperties":false,"submittable":true,"validators":null,"systemProperties":["id","project_id","created_datetime","updated_datetime","state"],"links":[{"name":"studies","backref":"cases","label":"member_of","target_type":"study","multiplicity":"many_to_many","required":true}],"required":["submitter_id","type","index_date","studies"],"uniqueKeys":[["id"],["project_id","submitter_id"]],"properties":{"$ref":"_definitions.yaml#/ubiquitous_properties","collaboration_id":{"description":"For instances in which multiple institutions use the same patient for their respective studies, this space is used as a place to enter in the de-identified barcode, id, or other identifier for the patient. Work with your collaborators to decide on the patient's id.\n","type":"string"},"index_date":{"description":"The reference or anchor date used during date obfuscation, where a single date is obscured by creating one or more date ranges in relation to this date.\n","enum":["Diagnosis","First Patient Visit","Study Enrollment","Not Applicable"]},"lost_to_followup":{"description":"A yes/no indicator related to whether a patient was unable to be contacted for follow-up.\n","enum":["Yes","No","Not Applicable"]},"days_to_lost_to_followup":{"description":"The number of days between the date used for index and the date the patient was lost to follow-up.\n","type":"integer"},"studies":{"$ref":"_definitions.yaml#/to_many"}}},"study.yaml":{"$schema":"http://json-schema.org/draft-04/schema#","id":"study","title":"Study","type":"object","namespace":"https://data.bloodpac.org","category":"administrative","program":"*","project":"*","description":"A coordinated set of actions and observations designed to generate data, with the ultimate goal of discovery or hypothesis testing.\n","additionalProperties":false,"submittable":true,"validators":null,"systemProperties":["id","project_id","created_datetime","updated_datetime","state"],"links":[{"name":"projects","backref":"studies","label":"performed_for","target_type":"project","multiplicity":"many_to_one","required":true}],"required":["submitter_id","type","data_description","study_description","study_design","study_objective","study_setup","projects"],"uniqueKeys":[["id"],["project_id","submitter_id"]],"properties":{"$ref":"_definitions.yaml#/ubiquitous_properties","associated_study":{"description":"The submitter_id for any study with which this study is associated, paired, or matched.","type":"string"},"data_description":{"description":"Brief description of the data being provided for this study. Free text","type":"string"},"study_description":{"description":"A brief description of the study being performed. Free text","type":"string"},"study_design":{"description":"Summary of the goals the study is designed to discover. General description of the study's place in relation to a clinical application.\n","enum":["Research/Early Development","Pre-Analytical","Analytical","Clinical","Clinical Assay","Clinical Utility"]},"study_objective":{"description":"The general objective of the study. What the study hopes to discover or determine through testing.\n","enum":["Accuracy","Clinical Detection","Interference","Limit of Detection","Precision (Repeatability)","Precision (Reproducibility)","Specificity/Sensitivity","Stability"]},"study_setup":{"description":"A high level description of the setup used to achieve the study objectives.\n","enum":["Detection/Enumeration/Isolation","Genetic Analysis"]},"projects":{"$ref":"_definitions.yaml#/to_one_project"}}}}
